e6vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
February 1, 2008
QIMONDA AG
Gustav-Heinemann-Ring 212
D-81739 Munich
Federal Republic of Germany
Tel: +49-89-60088-0
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
Indicate by check mark whether the registrant by furnishing the information contained in this Form
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection with
Rule 12g3-2(b): 82-________.
This Report on Form 6-K is incorporated by reference into the registration statement on Form
F-3, File No. 333-145983.
Explanatory Note
This Report on Form 6-K contains the quarterly report for the first financial quarter ended
December 31, 2007 of Qimonda AG dated February 1, 2008 and is hereby incorporated by reference into
our Registration Statement on Form F-3, Registration No. 333-145983.
QIMONDA AG AND
SUBSIDIARIES
QUARTERLY REPORT
FOR THE THREE MONTHS
ENDED
DECEMBER 31, 2007
INDEX
|
|
|
|
|
Page
|
|
|
|
1
|
|
|
10
|
|
|
11
|
|
|
12
|
|
|
13
|
|
|
14
|
|
|
32
|
|
|
34
|
i
(This page is intentionally left blank)
OVERVIEW OF
FINANCIAL RESULTS
Three Months
Ended December 31, 2007 Compared To Three Months Ended
December 31, 2006
Net
Sales
The following table presents data on our net sales for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Net sales
|
|
|
1,173
|
|
|
|
513
|
|
Effect of foreign exchange over prior period
|
|
|
(99
|
)
|
|
|
(65
|
)
|
% of net sales
|
|
|
(8%
|
)
|
|
|
(13%
|
)
|
Our net sales in the three months ended December 31, 2007
decreased by 660 million, or 56%, from
1,173 million in the three months ended
December 31, 2006 to 513 million in the three
months ended December 31, 2007. This decrease was primarily
due to:
|
|
|
|
|
an average price decline of 72% for our DRAM products;
|
|
|
|
a decrease in our non-PC bit shipment share from 58% to
45%; and
|
|
|
|
exchange rate effects due to the 11% weakening of the
U.S. dollar.
|
Offsetting this decrease in part was
|
|
|
|
|
an increase in bits shipped of 73%.
|
Price decreases. Following the steep price
decline of DRAM prices during the 2007 financial year, the three
months period ended December 31, 2007 was characterized by
a continued strong price decline. The main reason for this price
decline was the ongoing over-supply in the DRAM market which,
despite continued strong demand, drove down prices. DRAM bit
production in the industry continued to grow due to capacity
expansion and productivity growth resulting from the shift
towards more efficient technologies. This growth of DRAM bit
production continued to influence unfavorably the overall
supply-demand ratio.
During the three months ended December 31, 2006, by
contrast, average selling prices (for DDR2 memories in
particular) had increased to levels above those of the preceding
several quarters, due to product shortages based on insufficient
worldwide memory production capacities.
Overall the average selling prices of our DRAM products were 72%
lower in the three months ended December 31, 2007 as
compared to the three months ended December 31, 2006.
We continue to expect that prices for standard DRAM products
will decline over time across the industry as a whole. Such
declines can sometimes be severe, as we experienced in the last
several financial quarters. We intend to continue to follow our
strategy to mitigate the impact of declining prices by reducing
our costs per unit and continuing to diversify our product mix.
In the three months ended December 31, 2007, our share of
bit shipments to non-PC applications was 45% compared to 58% for
the three months ended December 31, 2006. This was mainly
due to weaker than usual seasonality in the three months ended
December 31, 2007 in the consumer and infrastructure
markets and, as a result of our accelerated technology
conversion, stronger shipments in the PC market to meet demand
growth.
Exchange rate effects. The U.S. dollar
weakened against the euro in the first three months of the 2008
financial year, with the average exchange rate for the period
11% lower than it was for the corresponding period of our 2007
financial year. This unfavorable U.S. dollar to euro
exchange rate negatively affected our revenues during the three
months ended December 31, 2007. We have calculated the
effects of this translation risk as follows: we would have
achieved 65 million more in net sales in the three
months ended December 31, 2007, had the average exchange
rates we used to translate our non-euro denominated sales into
euros been the same in the three months ended December 31,
2007 as they were in the three months ended December 31,
2006.
1
Increase in bit shipments. Our bit shipments
increased by 73% during the three months ended December 31,
2007 compared to the three months ended December 31, 2006
due to increasing manufacturing output, additional bit shipments
out of inventory and improved demand in all geographical
regions. Demand for our products was especially high in the PC
market, as PC makers increased the amount of DRAM per system (or
bits per box) in the current low price environment.
As of December 31, 2007, 56% of our capacities were
converted to the 80nm and below technology nodes, compared to
less than 5% for the three months ended December 31, 2006.
Net
Sales by Region
The following table sets forth our sales by region for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Germany
|
|
|
87
|
|
|
7%
|
|
|
36
|
|
|
7%
|
Rest of Europe
|
|
|
142
|
|
|
12%
|
|
|
50
|
|
|
10%
|
North America
|
|
|
474
|
|
|
40%
|
|
|
176
|
|
|
34%
|
Asia/Pacific
|
|
|
360
|
|
|
31%
|
|
|
184
|
|
|
36%
|
Japan
|
|
|
110
|
|
|
10%
|
|
|
67
|
|
|
13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,173
|
|
|
100%
|
|
|
513
|
|
|
100%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The relative increase in the share of sales in Asia/Pacific and
decrease in North America and Rest of Europe during the three
months ended December 31, 2007, was primarily caused by OEM
customers shifting their production to Asia, as well as regional
changes in product mix. The relative increase in the share of
sales in Japan resulted predominantly from additional design-in
wins, in particular for game consoles, and increased business
share for existing customers.
For practical purposes, the Rest of Europe region also includes
other countries and territories in the rest of the world outside
of the listed main geographic regions with aggregate sales
representing no more than 2% of total sales in any period. In
addition, prior period amounts have been reclassified to conform
to the current period presentation.
Cost
of Goods Sold and Gross Margin
The following table sets forth our cost of goods sold and
related data for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Cost of goods sold
|
|
|
(823
|
)
|
|
|
(927
|
)
|
% of net sales
|
|
|
70%
|
|
|
|
181%
|
|
Gross margin (loss)
|
|
|
30%
|
|
|
|
(81%
|
)
|
Cost of goods sold increased by 104 million, or 13%,
from 823 million in the three months ended
December 31, 2006 to 927 million in the three
months ended December 31, 2007. As a percentage of net
sales, cost of goods sold increased from 70% to 181% over the
same period. The absolute increase in our cost of goods sold was
due primarily to:
|
|
|
|
|
a 73% increase in bit shipments; and
|
|
|
|
negative effects of 122 million from inventory
revaluation and reserves.
|
Offsetting these increases in part were:
|
|
|
|
|
improvements in our productivity;
|
|
|
|
reduced purchase prices from our joint ventures and
foundries; and
|
|
|
|
exchange rate effects.
|
Higher bit shipments. The 73% increase in bit
shipments in the three months ended December 31, 2007
compared to the three months ended December 31, 2006 was
due primarily to the substantial increase in demand described
above, which we met through further
ramp-up of
production volumes at our
2
Richmond 300mm facility and higher purchases from foundries and
joint ventures. In addition, we reduced our finished good
inventory range measured in bits by approximately two weeks
compared to the three months ended September 30, 2007.
Inventory revaluation and reserves. We value
our inventory on a quarterly basis at the lower of cost or
market value. If the market price declines below the full
production cost of a particular product group, then all
inventories of that product group are written down to their
market price. The significant price decline in the three months
ended December 31, 2007 resulted in the write-down of
inventory to market value in an amount of 122 million
in accordance with our policy. Due to the volatility of the DRAM
market, write-downs of this nature may occur in periods of sharp
price decline.
Improved productivity. Similar to our 2007
financial year, we achieved productivity improvements through
the increased conversion of capacities to 80nm and 75nm process
technologies and the increasing share of our chips produced on
300mm wafers. The
ramp-up of
300mm capacities at our Richmond facility, our joint venture
Inotera and our foundry partners SMIC and Winbond contributed to
the increased share of production on 300mm wafers. Measured in
wafer starts, 82% of our total production (including capacity
sourced from our strategic and foundry partners) was on 300mm
wafers in the three months ended December 31, 2007 as
compared to 72% of our production in the three months ended
December 31, 2006. We believe that productivity
improvements, together with a larger sales volume over which our
fixed costs are spread, permitted us to achieve a lower
percentage increase in costs as compared to the percentage
increase in bit shipments. As of December 31, 2007, 56% of
our capacities were converted to the 80nm and below technology
nodes, compared to less than 5% for the three months ended
December 31, 2006. Other DRAM suppliers have been
converting their capacities to smaller feature sizes very
aggressively during the past few quarters and to keep pace we
have implemented measures to accelerate our conversion.
Decreased purchase prices from joint ventures and
foundries. Cost of goods sold includes the cost
of inventory purchased from our joint ventures, such as Inotera,
and other associated and related companies as well as our
foundry partners Winbond, SMIC and Infineon Dresden. Our
purchases from these entities amounted to 197 million
in the three months ended December 31, 2007 as compared to
378 million in the three months ended
December 31, 2006. Our purchases from these entities
declined in euro terms, as a result of the significant decline
in DRAM prices, although in the three months ended
December 31, 2007, we sourced 67% of our chips from these
partners as compared to 56% during the three months ended
December 31, 2006.
Exchange rate effects. The decline in the
exchange rate of the U.S. dollar against the euro in the
three months ended December 31, 2007, as compared to the
equivalent period one year earlier, decreased the euro value of
our costs that are denominated in U.S. dollars by
approximately 64 million. This means that we would
have incurred approximately 64 million more in costs
of goods sold in our three months ended December 31, 2007,
had the average exchange rates we used to translate our non-euro
expenses into euros been the same in the three months ended
December 31, 2007 as they were in the three months ended
December 31, 2006. However, considered together with the
decrease in our net sales due to negative foreign exchange
effects of 65 million, foreign currency movements
overall had no significant net effect on our gross margin during
the three months ended December 31, 2007.
Our gross margin decreased to a negative 81% during the three
months ended December 31, 2007, from a positive 30% in the
three months ended December 31, 2006, primarily due to
lower average selling prices and inventory write downs due to
lower selling prices which could not be compensated by lower
production cost per unit resulting from increased manufacturing
productivity and lower transfer prices from foundry partners.
While average selling prices, especially for standard DRAM
products, generally decline over time, they can display
significant volatility from period to period. Our gross margin
suffers in periods, such as each of our most recent financial
quarters, in which prices decline faster than we can reduce our
unit costs. Conversely, our gross margin is stronger during
periods when prices decrease more slowly or increase, such as at
the end of our 2006 financial year.
3
Research
and Development (R&D) Expenses
The following table sets forth our R&D expenses for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Research and development expenses
|
|
|
(97
|
)
|
|
|
(110
|
)
|
% of net sales
|
|
|
8%
|
|
|
|
21%
|
|
In the three months ended December 31, 2007, research and
development expenses increased by 13% to 110 million,
from 97 million in the three months ended
December 31, 2006, due to our efforts to strengthen our
development capabilities with respect to the next generation of
memory technologies and further diversification our portfolio of
memory products as well as to strengthen our development
capabilities with respect to non-volatile memory technologies.
In the three months ended December 31, 2006, our research
and development expenses were low due to the substantial
completion of technology development for 80nm and 75nm during
September and October 2006, respectively.
The goal of our current technology development efforts is to
support our product designers in meeting customer requirements
regarding high performance, low power consumption and small form
factors at a competitive cost level as the industry migrates to
even smaller feature sizes. In December, we presented our full
integration scheme of a 48nm DRAM trench technology at the
Institute of Electrical and Electronics Engineers annual
International Election Devices Meeting. The technology we
presented features an innovative wiring scheme that we believe
enables a lower process complexity and power consumption across
future DRAM architectures as compared to current approaches. At
the same time we are working on new DRAM architectures that are
implementing similar wiring schemes and that we believe will
allow us to reduce the cell size of our DRAM products towards
4F2
over the next several years, consistent with our views on the
progression of the industry, while at the same time meeting
customer requirements regarding high performance and low power
consumption. These new architectures combine a variety of
innovations on the cell and wiring level, and we are currently
spending additional R&D efforts to introduce them in first
product designs. Because the degree of innovation, testing and
other development work that is involved with a progression to
these new architectures exceeds that required for the reductions
in feature sizes we have implemented in recent technology
generations, we may be unable to meet our goals or keep pace
with the rate of development in the industry in a timely manner
or at all, or do so at competitive costs. In addition, the
increased R&D work in which we are currently engaged and
expect to continue in the coming financial periods will add to
demands for capital. See Liquidity Capital
Requirements.
Selling,
General and Administrative (SG&A) Expenses
The following table sets forth information on our selling,
general and administrative expenses for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Selling, general and administrative expenses
|
|
|
(44
|
)
|
|
|
(48
|
)
|
% of net sales
|
|
|
4%
|
|
|
|
9%
|
|
During the three months ended December 31, 2007, selling,
general and administrative expenses increased by 9% as compared
to the same period in the prior year. The increase as a
percentage of sales was mainly attributable to the decrease in
sales compared to the prior year. The primary reason for this
increase in euro absolute terms is the shift of reporting
category for our distribution center expenses from cost of goods
sold to selling expenses.
4
Restructuring
Expenses
The following table sets forth information on our restructuring
expenses for the periods indicated.
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Restructuring expenses
|
|
|
0
|
|
|
(16
|
)
|
% of net sales
|
|
|
0%
|
|
|
3%
|
|
Our restructuring expenses comprise expenses for our research
activities in North America and our phase-out of 200mm
manufacturing. Due to continued efforts to improve cost and
efficiency, we decided to consolidate our U.S. research and
development facilities in a single development center located in
Raleigh, North Carolina. As a result, the Companys
development center in Burlington, Vermont, is to be closed at
the end of June 2008. Furthermore, as part of our focus on
improved profitability and 300mm manufacturing, we terminated
our wafer purchase contract with Infineon on November 30,
2007. We had previously agreed to share 50% of the restructuring
costs which Infineon will occur in connection with the
termination of this contract. In addition, included in cost of
sales are 17 million related to purchase commitments
for 200mm wafer contract manufacturing at Infineon Dresden. We
currently anticipate additional costs of 4 million
related to these measures which are to be expensed as they are
incurred during our 2008 financial year. Additionally, the
companies are presently discussing additional reimbursement from
us for idle costs of approximately 20 million which
have not been incurred or accrued as of December 31, 2007.
Other
Operating (Expense) Income, Net
The following table sets forth information on our other
operating (expense) income, net for the periods indicated.
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Other operating income (expense), net
|
|
|
0
|
|
|
3
|
% of net sales
|
|
|
0%
|
|
|
1%
|
Other operating (expense) income, net contains various items
related to our operations, and may fluctuate from period to
period due to the more or less infrequent nature of these items,
which include subsidies, grants, insurance proceeds and accruals
for legal matters. No material costs of this nature were
incurred in the three months ended December 31, 2006 as
well as in the three months ended December 31, 2007.
Equity
in Earnings of Associated Companies
The following table sets forth information on our equity in
earnings of associated companies for the periods indicated.
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Equity in earnings of associated companies
|
|
|
37
|
|
|
2
|
% of net sales
|
|
|
3%
|
|
|
0%
|
The equity in earnings of associated companies with financial
year ends that differ by not more than three months from the
Companys financial year end is recorded with a three month
delay. This applies in particular to our joint venture Inotera
Memories, which has a December 31 financial year-end. Market
price fluctuations during the three months ended
December 31, 2007 would, to the extent these impact
Inoteras results, affect our equity in Inoteras
earnings during the three months ending March 31, 2008.
In both periods, Inotera contributed most of our equity in
earnings from associated companies, which decreased in the three
months ended December 31, 2007, mainly due to lower selling
prices in the three months ended September 30, 2007. Our
equity in Inoteras earnings is, however, sensitive not
only to fluctuations in the price of DRAM and production
volumes, but also to changes in the portion of our
5
inventory which we purchased from Inotera and that remains
unsold. This is because we eliminate Inoteras profit from
the inventory we have not yet sold.
Loss
on Associated Company Share Issuance
The following table sets forth information on our loss on
associated company share issuance for the periods indicated.
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Loss on associated company share issuance
|
|
|
0
|
|
|
(7
|
)
|
% of net sales
|
|
|
0%
|
|
|
1%
|
|
On August 20, 2007 Inotera issued 40 million common
shares, representing 1.2% of its outstanding share capital, as
bonuses to its employees. This diluted our ownership interest to
35.6%, which amounted to a loss of 7 million.
Other
Non-Operating Income, Net
The following table sets forth information on other
non-operating income for the periods indicated.
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Other non-operating income, net
|
|
|
5
|
|
|
2
|
% of net sales
|
|
|
0%
|
|
|
0%
|
Other non-operating income, net consists of various items from
period to period not directly related to our principal
operations, including gains and losses on sales of marketable
securities. In the three months ended December 31, 2007,
other non-operating income related mainly to the valuation of
derivatives and gains and losses on sales of marketable
securities, whereas in the three months ended December 31,
2006, other non-operating income related principally to foreign
currency transaction gains and a gain of 2 million on
the sale of our investment in Ramtron.
Earnings
(Loss) Before Interest and Taxes
(EBIT)
EBIT is a non-GAAP financial measure which is determined from
our combined and consolidated statements of operations as
follows:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Net income (loss)
|
|
|
177
|
|
|
|
(598
|
)
|
Add: interest expense (income)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Add: income tax expense (benefit)
|
|
|
74
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
EBIT
|
|
|
250
|
|
|
|
(590
|
)
|
Interest
Income, Net
The following table sets forth information on our net interest
income, net for the periods indicated.
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Interest income, net
|
|
|
1
|
|
|
1
|
% of net sales
|
|
|
0%
|
|
|
0%
|
Interest expense mainly relates to interest on the recently
completed sale and lease back transactions, while we earn
interest income on cash and cash equivalents and marketable
securities.
6
Income
Taxes
The following table sets forth information on our income taxes
for the periods indicated.
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions, except percentages)
|
|
Income tax (expense) benefit
|
|
|
(74
|
)
|
|
(9)
|
% of net sales
|
|
|
6%
|
|
|
2%
|
Effective tax rate
|
|
|
29%
|
|
|
(2%)
|
On August 17, 2007 the Business Tax Reform Act of 2008 was
enacted in Germany. This bill introduces several changes to the
taxation of German business activities, including a reduction of
the combined corporate and trade tax rate in Germany from
approximately 39% to 30%. Most of the changes apply to us from
October 1, 2007 and affect our current tax rate from that
date.
In each of the three months ended December 31, 2006 and
2007, our effective tax rate was lower than the combined
statutory tax rate in Germany of 39% and 30%, respectively. This
resulted mainly from income in jurisdictions with lower than
average corporate tax rates, tax credits, and in the three
months ended December 31, 2007 additional valuation
allowances against current period tax benefits.
Pursuant to SFAS No. 109, we have assessed our
deferred tax asset and the need for a valuation allowance. The
assessment was based on the benefits that could be realized from
available tax strategies, forecasted future taxable income to
the extent applicable, and the reversal of temporary differences
in future periods. As a result of this assessment, we increased
our deferred tax asset valuation allowance as of
December 31, 2007 to reduce the deferred tax asset to an
amount that is more likely than not expected to be realized in
the future.
Despite our consolidated pretax loss, we generated taxable
income in certain tax jurisdictions which resulted in the
negative effective tax rate during the three months ended
December 31, 2007.
On October 1, 2007 we adopted FIN 48, which prescribes
the accounting and reporting of uncertainties in income tax law.
The adoption did not affect our financial statements. We had a
recorded liability for unrecognized tax benefits of
45 million as of December 31, 2007, which would
favorably affect our effective tax rate, if recognized in future
periods. We do not expect this amount to change significantly
during the remainder of our 2008 financial year.
Net
Income (Loss)
We had a net loss of 598 million in the three months
ended December 31, 2007 compared to net income of
177 million in the three months ended
December 31, 2006.
Financial
Condition
The following table sets forth selected items from our
consolidated balance sheets for the periods indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
|
|
September 30
|
|
December 31
|
|
|
|
|
2007
|
|
2007
|
|
Change(1)
|
|
|
(in millions, except
|
|
%
|
|
|
percentages)
|
|
|
|
Current assets
|
|
|
2,257
|
|
|
1,668
|
|
|
(26%
|
)
|
Non-Current assets
|
|
|
3,124
|
|
|
3,048
|
|
|
(2%
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
5,381
|
|
|
4,716
|
|
|
(12%
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
1,244
|
|
|
1,184
|
|
|
(5%
|
)
|
Non-current liabilities
|
|
|
620
|
|
|
659
|
|
|
6%
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
1,864
|
|
|
1,843
|
|
|
(1%
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity
|
|
|
3,517
|
|
|
2,873
|
|
|
(18%
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Percentage changes from September 30, 2007 to
December 31, 2007. |
7
As of December 31, 2007, our current assets decreased
significantly as compared to September 30, 2007 mainly due
to lower cash and cash equivalents, lower inventories and lower
trade accounts receivables. Trade accounts receivables decreased
in the three months ended December 31, 2007 mainly due to
lower sales. Inventories decreased as a result of lower gross
inventories and higher inventory write-downs due to market price
decline in the three months ended December 31, 2007
compared to September 30, 2007. As of December 31,
2007, non-current assets decreased slightly compared to
September 30, 2007 mainly due to a decrease in property,
plant and equipment because our capital expenditures were lower
than our depreciation expense.
As of December 31, 2007, current liabilities decreased
compared to September 30, 2007 mainly due to lower trade
accounts payable as a result of lower capital expenditures in
the three months ended December 31, 2007 compared to the
three months ended September 30, 2007. As of
December 31, 2007, non-current liabilities increased
compared to September 30, 2007 mainly due to increased
long-term debt as a result of our sale and leaseback
transactions, partly offset by the redemption of other
non-current liabilities.
As of December 31, 2007, our shareholders equity
decreased to 2,873 million, mainly due to our net
loss of 598 million during the three months ended
December 31, 2007, and foreign currency translation losses
affecting equity of 45 million.
Liquidity
Cash
Flows
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions)
|
|
Net cash provided by (used in) operating activities
|
|
|
438
|
|
|
|
(158
|
)
|
Net cash used in investing activities
|
|
|
(208
|
)
|
|
|
(35
|
)
|
Net cash provided by (used in) financing activities
|
|
|
(104
|
)
|
|
|
(38
|
)
|
Effect of foreign exchange rate changes on cash and cash
equivalents
|
|
|
(5
|
)
|
|
|
(6
|
)
|
Cash and cash equivalents at end of period
|
|
|
1,053
|
|
|
|
509
|
|
Our operating cash flow decreased significantly from an inflow
of 438 million in the three months ended
December 31, 2006 to an outflow of 158 million
in the three months ended December 31, 2007. This was
mainly caused by our net loss of 598 million in the
three months ended December 31, 2007, which in turn was
largely a result of lower net sales due to the strong decline in
our average selling prices. This negative impact in our
operating cash flow was partly offset by working capital
improvements resulting from the decrease in our inventories and
trade accounts receivable. The decrease in trade accounts
payable also negatively impacted operating cash flow during the
three months ended December 31, 2007 compared to the three
months ended December 31, 2006.
Cash used in investing activities decreased substantially from
an outflow of 208 million in the three months ended
December 31, 2006 to an outflow of 35 million in
the three months ended December 31, 2007. This resulted
mainly from lower capital expenditures in property, plant and
equipment and from proceeds we received from sales of marketable
securities and the closings of our sale and leaseback
transactions.
Cash used in financing activities during the three months ended
December 31, 2007 refers mainly to changes in short term
borrowing and repayments under capital lease obligations. During
the three months ended December 31, 2006, cash used in
financing refers principally to the repayment of
112 million of short-term debt to Infineon. In
October 2007 we fully repaid 28 million short-term
notes payable to banks which had been drawn as of
September 30, 2007 for working capital purposes.
8
Free
Cash Flow
Free cash flow is a non-GAAP financial measure which is
determined as follows from our combined and consolidated
statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions)
|
|
Net cash provided by (used in) operating activities
|
|
|
438
|
|
|
|
(158
|
)
|
Net cash used in investing activities
|
|
|
(208
|
)
|
|
|
(35
|
)
|
Purchases (proceeds) of marketable securities, net
|
|
|
11
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
|
|
|
Free Cash Flow
|
|
|
241
|
|
|
|
(217
|
)
|
|
|
|
|
|
|
|
|
|
Our free cash flow in the three months ended December 31,
2007, was negative mainly due to our current non-profitable
operations and capital expenditures that were higher than our
proceeds from sale and leaseback transactions.
The free cash flow was positive in the three months ended
December 31, 2006 mainly due to our profitable operations
and capital expenditures that were lower than cash provided from
operating activities.
Capital
Expenditures
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
December 31,
|
|
|
2006
|
|
2007
|
|
|
(in millions)
|
|
Purchases of property, plant and equipment
|
|
|
221
|
|
|
190
|
Our capital expenditures for the three months ended
December 31, 2007, consisted primarily of equipment for the
technology conversion at our 300mm fab in Richmond, Virginia and
for our 300mm R&D facility in Dresden.
We have reduced our target for capital expenditures for the 2008
financial year to a range of 400 million to
500 million and put on hold the construction of a new
300mm fab in Singapore pending improving market conditions.
Capital
Requirements
We had aggregate cash, cash equivalents and available-for-sale
marketable securities as of December 31, 2007 of
746 million, which we refer to as our gross cash
position, compared to 1,011 million as of
September 30, 2007. As of December 31, 2007 we had
debt obligations of 68 million payable within one year.
Our total short and long-term debt amounted to
372 million as of December 31, 2007, which
represents 13 percent of our shareholders equity at
the same date. We therefore believe that our capital structure
provides us with flexibility to obtain financing suitable to our
business, such as the sale and lease back transactions we have
recently executed despite difficult global financial market
conditions.
We intend to explore a wide range of potential sources of
capital, including capital markets transactions, debt financing,
leverage of selected assets and ventures with third parties. To
the extent our performance remains at current levels or
deteriorates further, which we view to a substantial extent as
dependent on price developments for DRAM products, we may have
difficulty obtaining capital.
Outlook for the
Second Quarter and 2008 Financial Year
For the 2008 financial year, we are targeting an increase in our
bit production between 30 to 40 percent as compared to our
prior estimate of 50 percent, taking into account our
accelerated reduction of 200mm capacities, which is partly
offset by productivity improvements through our conversion to
80nm and 75nm technologies.
For the second quarter, we currently expect our bit production
to increase by a mid single digit percentage compared to the
first quarter. Additionally, we are currently reassessing our
capacity corridors with foundry partners in light of the
relatively low DRAM market price environment.
For the 2008 financial year, we continue to expect bit demand
for DRAM to be driven by continued solid growth in graphics,
consumer and communication applications and the move to higher
density modules in the PC market. We expect our share of
bit-shipments for use in non-PC applications to be greater than
50 percent for the full 2008 financial year.
9
Qimonda AG and
Subsidiaries
Condensed
Consolidated Statements of Operations (Unaudited)
For the three months ended December 31, 2006 and
2007
(in millions, except for share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
Notes
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
()
|
|
|
()
|
|
|
($)
|
|
|
Net sales to third parties
|
|
|
18
|
|
|
|
1,173
|
|
|
|
513
|
|
|
|
749
|
|
Cost of goods sold
|
|
|
|
|
|
|
(823
|
)
|
|
|
(927
|
)
|
|
|
(1,353
|
)
|
|
|
Gross profit
|
|
|
|
|
|
|
350
|
|
|
|
(414
|
)
|
|
|
(604
|
)
|
|
|
Research and development expenses
|
|
|
|
|
|
|
(97
|
)
|
|
|
(110
|
)
|
|
|
(161
|
)
|
Selling, general and administrative expenses
|
|
|
|
|
|
|
(44
|
)
|
|
|
(48
|
)
|
|
|
(70
|
)
|
Restructuring charges
|
|
|
3
|
|
|
|
|
|
|
|
(16
|
)
|
|
|
(23
|
)
|
Other operating income, net
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
4
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
|
209
|
|
|
|
(585
|
)
|
|
|
(854
|
)
|
|
|
Interest income, net
|
|
|
14
|
|
|
|
1
|
|
|
|
1
|
|
|
|
1
|
|
Equity in earnings of associated companies
|
|
|
8
|
|
|
|
37
|
|
|
|
2
|
|
|
|
3
|
|
Loss on associated company share issuance
|
|
|
8
|
|
|
|
|
|
|
|
(7
|
)
|
|
|
(10
|
)
|
Other non-operating income, net
|
|
|
|
|
|
|
5
|
|
|
|
2
|
|
|
|
3
|
|
Minority interests
|
|
|
|
|
|
|
(1
|
)
|
|
|
(2
|
)
|
|
|
(3
|
)
|
|
|
Income (loss) before income taxes
|
|
|
|
|
|
|
251
|
|
|
|
(589
|
)
|
|
|
(860
|
)
|
|
|
Income tax expense
|
|
|
4
|
|
|
|
(74
|
)
|
|
|
(9
|
)
|
|
|
(13
|
)
|
|
|
Net income (loss)
|
|
|
|
|
|
|
177
|
|
|
|
(598
|
)
|
|
|
(873
|
)
|
|
|
Basic and diluted earnings (loss) per share
|
|
|
5
|
|
|
|
0.52
|
|
|
|
(1.75
|
)
|
|
|
(2.56
|
)
|
See accompanying notes to the unaudited condensed consolidated
financial statements.
10
Qimonda AG and
Subsidiaries
Condensed
Consolidated Balance Sheets (Unaudited)
As of September 30, 2007 and December 31,
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
Notes
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
( millions)
|
|
|
( millions)
|
|
|
($ millions)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
746
|
|
|
|
509
|
|
|
|
743
|
|
Marketable securities
|
|
|
|
|
|
|
265
|
|
|
|
237
|
|
|
|
346
|
|
Trade accounts receivable, net
|
|
|
6
|
|
|
|
341
|
|
|
|
258
|
|
|
|
377
|
|
Inventories
|
|
|
7
|
|
|
|
619
|
|
|
|
386
|
|
|
|
564
|
|
Deferred income taxes
|
|
|
4
|
|
|
|
32
|
|
|
|
38
|
|
|
|
55
|
|
Other current assets
|
|
|
|
|
|
|
254
|
|
|
|
240
|
|
|
|
350
|
|
|
|
Total current assets
|
|
|
|
|
|
|
2,257
|
|
|
|
1,668
|
|
|
|
2,435
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
2,186
|
|
|
|
2,146
|
|
|
|
3,134
|
|
Intangible assets, net
|
|
|
|
|
|
|
143
|
|
|
|
138
|
|
|
|
202
|
|
Long-term investments
|
|
|
8
|
|
|
|
628
|
|
|
|
594
|
|
|
|
867
|
|
Deferred income taxes
|
|
|
4
|
|
|
|
147
|
|
|
|
151
|
|
|
|
221
|
|
Other assets
|
|
|
|
|
|
|
20
|
|
|
|
19
|
|
|
|
28
|
|
|
|
Total assets
|
|
|
|
|
|
|
5,381
|
|
|
|
4,716
|
|
|
|
6,887
|
|
|
|
Liabilities and shareholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current maturities
|
|
|
10, 14
|
|
|
|
77
|
|
|
|
68
|
|
|
|
99
|
|
Trade accounts payable
|
|
|
9
|
|
|
|
756
|
|
|
|
704
|
|
|
|
1,029
|
|
Accrued liabilities
|
|
|
|
|
|
|
147
|
|
|
|
146
|
|
|
|
213
|
|
Deferred income taxes
|
|
|
4
|
|
|
|
5
|
|
|
|
5
|
|
|
|
7
|
|
Other current liabilities
|
|
|
|
|
|
|
259
|
|
|
|
261
|
|
|
|
381
|
|
|
|
Total current liabilities
|
|
|
|
|
|
|
1,244
|
|
|
|
1,184
|
|
|
|
1,729
|
|
|
|
Long-term debt
|
|
|
10
|
|
|
|
227
|
|
|
|
304
|
|
|
|
444
|
|
Pension liabilities
|
|
|
15
|
|
|
|
25
|
|
|
|
25
|
|
|
|
37
|
|
Deferred income taxes
|
|
|
4
|
|
|
|
23
|
|
|
|
26
|
|
|
|
38
|
|
Long-term accrued liabilities
|
|
|
|
|
|
|
14
|
|
|
|
18
|
|
|
|
26
|
|
Other liabilities
|
|
|
|
|
|
|
248
|
|
|
|
202
|
|
|
|
295
|
|
Minority interest
|
|
|
|
|
|
|
83
|
|
|
|
84
|
|
|
|
123
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
1,864
|
|
|
|
1,843
|
|
|
|
2,692
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary share capital
|
|
|
|
|
|
|
684
|
|
|
|
684
|
|
|
|
999
|
|
Additional paid-in capital
|
|
|
|
|
|
|
3,117
|
|
|
|
3,118
|
|
|
|
4,553
|
|
Accumulated deficit
|
|
|
|
|
|
|
(25
|
)
|
|
|
(623
|
)
|
|
|
(910
|
)
|
Accumulated other comprehensive loss
|
|
|
12
|
|
|
|
(259
|
)
|
|
|
(306
|
)
|
|
|
(447
|
)
|
|
|
Total shareholders equity
|
|
|
|
|
|
|
3,517
|
|
|
|
2,873
|
|
|
|
4,195
|
|
|
|
Total liabilities and shareholders equity
|
|
|
|
|
|
|
5,381
|
|
|
|
4,716
|
|
|
|
6,887
|
|
|
|
See accompanying notes to the unaudited condensed consolidated
financial statements.
11
Qimonda AG and Subsidiaries
For the three months ended December 31, 2006 and
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
earnings
|
|
|
other
|
|
|
|
|
|
|
|
|
|
Issued Ordinary shares
|
|
|
paid-in
|
|
|
(accumulated
|
|
|
comprehensive
|
|
|
|
|
|
|
Notes
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
deficit)
|
|
|
(loss) income
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
(millions)
|
|
|
( millions)
|
|
|
( millions)
|
|
|
( millions)
|
|
|
( millions)
|
|
|
( millions)
|
|
|
Balance as of October 1, 2006
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,097
|
|
|
|
224
|
|
|
|
(134
|
)
|
|
|
3,871
|
|
|
|
Contribution by Infineon
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
177
|
|
|
|
|
|
|
|
177
|
|
Stock-based compensation
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
Other comprehensive loss
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(54
|
)
|
|
|
(54
|
)
|
|
|
Balance as of December 31, 2006
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,111
|
|
|
|
401
|
|
|
|
(188
|
)
|
|
|
4,008
|
|
|
|
Balance as of October 1, 2007
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,117
|
|
|
|
(25
|
)
|
|
|
(259
|
)
|
|
|
3,517
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(598
|
)
|
|
|
|
|
|
|
(598
|
)
|
Stock-based compensation
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Other comprehensive loss
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(47
|
)
|
|
|
(47
|
)
|
|
|
Balance as of December 31, 2007
|
|
|
|
|
|
|
342
|
|
|
|
684
|
|
|
|
3,118
|
|
|
|
(623
|
)
|
|
|
(306
|
)
|
|
|
2,873
|
|
|
|
See accompanying notes to the unaudited condensed consolidated
financial statements.
12
Qimonda AG and
Subsidiaries
For the three months ended December 31, 2006 and
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
Notes
|
|
|
2006
|
|
|
2007
|
|
|
2007
|
|
|
|
|
|
|
|
|
( millions)
|
|
|
( millions)
|
|
|
($ millions)
|
|
|
Net income (loss)
|
|
|
|
|
|
|
177
|
|
|
|
(598
|
)
|
|
|
(873
|
)
|
Adjustments to reconcile net income (loss) to cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
161
|
|
|
|
163
|
|
|
|
238
|
|
Gain on sales of business interests
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
Gain on sales of long-term assets
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
Gain on sales of marketable securities
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
1
|
|
Equity in earnings of associated companies
|
|
|
|
|
|
|
(37
|
)
|
|
|
(2
|
)
|
|
|
(3
|
)
|
Loss on associate company share issuance
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
10
|
|
Stock-based compensation
|
|
|
11
|
|
|
|
2
|
|
|
|
1
|
|
|
|
1
|
|
Minority interests
|
|
|
|
|
|
|
1
|
|
|
|
2
|
|
|
|
3
|
|
Deferred income taxes
|
|
|
4
|
|
|
|
10
|
|
|
|
1
|
|
|
|
1
|
|
Due to changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
6
|
|
|
|
122
|
|
|
|
81
|
|
|
|
118
|
|
Inventories
|
|
|
7
|
|
|
|
(71
|
)
|
|
|
232
|
|
|
|
339
|
|
Other current assets
|
|
|
|
|
|
|
4
|
|
|
|
14
|
|
|
|
20
|
|
Trade accounts payable
|
|
|
9
|
|
|
|
54
|
|
|
|
(51
|
)
|
|
|
(74
|
)
|
Accrued liabilities
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
|
|
|
|
36
|
|
|
|
9
|
|
|
|
13
|
|
Other assets and liabilities
|
|
|
|
|
|
|
(11
|
)
|
|
|
(18
|
)
|
|
|
(26
|
)
|
|
|
Net cash provided by (used in) operating activities
|
|
|
|
|
|
|
438
|
|
|
|
(158
|
)
|
|
|
(232
|
)
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of marketable securities available for sale
|
|
|
|
|
|
|
(11
|
)
|
|
|
(35
|
)
|
|
|
(51
|
)
|
Proceeds from sales of marketable securities available for sale
|
|
|
|
|
|
|
|
|
|
|
59
|
|
|
|
86
|
|
Proceeds from disposal of business interests
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
|
|
Purchases of intangible assets
|
|
|
|
|
|
|
(6
|
)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Purchases of property, plant and equipment
|
|
|
|
|
|
|
(221
|
)
|
|
|
(190
|
)
|
|
|
(277
|
)
|
Proceeds from sales of long-term assets
|
|
|
|
|
|
|
3
|
|
|
|
132
|
|
|
|
193
|
|
|
|
Net cash used in investing activities
|
|
|
|
|
|
|
(208
|
)
|
|
|
(35
|
)
|
|
|
(50
|
)
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in short-term debt due Infineon
|
|
|
14
|
|
|
|
(112
|
)
|
|
|
|
|
|
|
|
|
Repayments of short-term debt due third parties
|
|
|
10
|
|
|
|
|
|
|
|
(28
|
)
|
|
|
(41
|
)
|
Decrease in financial payables due related parties
|
|
|
14
|
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
Principal repayments under capital lease obligations
|
|
|
10
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
(15
|
)
|
Contribution by and advances from Infineon
|
|
|
1
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
|
|
|
|
(104
|
)
|
|
|
(38
|
)
|
|
|
(56
|
)
|
|
|
Effect of foreign exchange rate changes on cash and cash
equivalents
|
|
|
|
|
|
|
(5
|
)
|
|
|
(6
|
)
|
|
|
(9
|
)
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
|
|
|
|
121
|
|
|
|
(237
|
)
|
|
|
(347
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
932
|
|
|
|
746
|
|
|
|
1,090
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
|
|
|
|
1,053
|
|
|
|
509
|
|
|
|
743
|
|
|
|
See accompanying notes to the unaudited condensed consolidated
financial statements.
13
Qimonda AG and
Subsidiaries
(euro in millions, except where otherwise stated)
|
|
1.
|
Description of
Business, Formation and Basis of Presentation
|
Description of
Business
Qimonda AG and its subsidiaries (collectively, the
Company or Qimonda) is one of the
worlds leading suppliers of semiconductor memory products.
Qimonda designs memory technologies and develops, manufactures,
markets and sells a large variety of memory products on a
module, component and chip level. Qimonda has operations,
investments and customers located mainly in Europe, Asia and
North America. The Company is a majority-owned subsidiary of
Infineon Technologies AG and its subsidiaries
(Infineon). The financial year-end for the Company
is September 30.
Formation
Effective May 1, 2006, substantially all the memory
products-related assets and liabilities, operations and
activities of Infineon (the Memory Products
business) were contributed to the Company (the
Formation). In conjunction with the Formation the
Company entered into a contribution agreement and various other
service agreements with Infineon.
At the Formation certain of the Companys operations and
investments that could not be directly transferred were
initially held in trust for Qimondas benefit by Infineon
until the legal transfer to Qimonda could take place. Pursuant
to agreements entered into on December 14, 2007
Infineons investments in Advanced Mask Technology Center
GmbH & Co. (AMTC) and Maskhouse Building
Administration GmbH & Co. KG (BAC) are to
be transferred to Qimonda subject to registration in the
commercial register (note 19). The accompanying financial
statements include the results of operations of these activities
for all periods presented.
Basis of
Presentation
The accompanying condensed consolidated financial statements as
of and for the three months ended December 31, 2006 and
2007, have been prepared in accordance with accounting
principles generally accepted in the United States of America
(U.S. GAAP). The accompanying financial statements are
condensed, because certain information and footnote disclosures
normally included in annual financial statements have been
condensed or omitted. In addition, the condensed consolidated
balance sheet as of September 30, 2007 was derived from
audited financial statements and condensed for comparative
purposes, but does not include all disclosures required by
U.S. GAAP. In the opinion of management, the accompanying
condensed consolidated financial statements contain all
adjustments necessary to present fairly the financial position,
results of operations and cash flows of the interim periods
presented. All such adjustments are of a normal recurring
nature. The results of operations for any interim period are not
necessarily indicative of results for the full financial year.
The accompanying condensed consolidated financial statements
should be read in conjunction with the audited combined and
consolidated financial statements for the year ended
September 30, 2007. The accounting policies applied in
preparing the accompanying condensed financial statements are
consistent with those for the year ended September 30, 2007
(note 2).
All amounts herein are shown in millions of euro (or
) except where otherwise stated.
The accompanying balance sheet as of December 31,
2007, and the statements of operations and cash flows for the
periods then ended are also presented in U.S. dollars
($), solely for the convenience of the reader, at
the rate of 1 = $1.4603, the Federal Reserve noon buying
rate on December 31, 2007.
Certain amounts in prior periods condensed consolidated
financial statements and notes have been reclassified to conform
to the current period presentation. Intangible assets, pension
liabilities and minority interest are presented separately on
the Companys balance sheet. The Companys
consolidated results of operations, financial position or
overall cash flows have not been affected by these
reclassifications.
Estimates
The preparation of the accompanying condensed consolidated
financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities, as
14
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
well as disclosure of contingent amounts and liabilities, at the
date of the financial statements and the reported amounts of
revenues and expenses during the periods presented. Actual
results could differ materially from such estimates made by
management.
|
|
2.
|
Recent Accounting
Pronouncements
|
Adopted in the
year beginning October 1, 2007
In July 2006, the FASB issued FASB Interpretation No. 48,
Accounting for Uncertainty in Income Taxes
an interpretation of FASB Statement No. 109
(FIN 48) which defines the threshold for
recognizing the benefits of tax return positions in the
financial statements as more-likely-than-not to be
sustained by the taxing authority. FIN 48 also provides
guidance on the de-recognition measurement and classification of
income tax uncertainties, along with any related interest and
penalties. FIN 48 also includes guidance concerning
accounting for income tax uncertainties in interim periods and
increases the level of disclosures associated with any recorded
income tax uncertainties. The Company adopted FIN 48
beginning October 1, 2007 (note 4).
Issued since
October 1, 2007 but principally applicable in future
financial years
In December 2007, the FASB issued SFAS No. 141(R)
Business Combinations.
SFAS No. 141(R) replaces FASB Statement No. 141,
Business Combinations and requires the acquiring entity in a
business combination to recognize all the assets acquired and
liabilities assumed in the transaction even if the business is
not acquired by 100% by the acquirer. The revised statement
establishes the acquisition-date fair value as the measurement
objective for all assets acquired and liabilities assumed.
Further major differences to the current accounting practices
are the definition of a business, the shift from the
purchase method to the acquisition method, a changed treatment
of acquisition and restructuring costs related to the
acquirement and the recognition of contingent assets, contingent
liabilities and contingent considerations. The new SFAS No
.141(R) will be effective prospectively for fiscal years
beginning on or after December 15, 2008. The company is
currently evaluating the impact on its results of operations or
financial position.
In December 2007, the FASB issued SFAS No. 160
Noncontrolling Interests in Consolidated Financials
Statements an Amendment of ARB No .51.
SFAS No. 160 requires companies to measure an
acquisition of a noncontrolling (minority) interest at fair
value in the equity section of the acquiring entitys
balance sheet. The new SFAS No .160 will be effective
prospectively for fiscal years beginning on or after
December 15, 2008. For presentation and disclosure
requirements the new statement has to be applied retrospectively
for all periods presented. The company is currently evaluating
the impact on its results of operations or financial position.
During the three months ended December 31, 2007 Qimonda
announced restructuring measures aimed at reducing costs by
focusing efforts on faster conversions to cost efficient
technologies. The Companys restructuring expenses comprise
expenses for the phase-out of 200mm manufacturing and the
combination of research activities in North America. The Company
had accrued restructuring costs of 16 as of
December 31, 2007 related to these measures. The Company
currently anticipates additional costs of 4 related to
these measures which are to be expensed as they are incurred
during the year ending September 30, 2008.
Dresden 200mm
Facility
In April 2006, Infineon and Qimonda entered into a product
purchase agreement for the production of 200mm wafers by
Infineon Technologies Dresden GmbH & Co. OHG
(DD200) through September 30, 2007. In January
2007, the agreement was extended through September 30,
2009. Pursuant to the agreement, Infineon agreed to manufacture
wafers at DD200, using the Companys manufacturing
technologies and masks, and to sell them to the Company at
prices specified in the agreement. The Company agreed to pay for
idle costs resulting from its purchasing fewer wafers from
Infineon than agreed
15
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
upon, if Infineon cannot otherwise utilize the capacity.
Infineon and the Company agreed to share equally any potential
restructuring costs arising in connection with one DD200 module.
As part of its focus on improved profitability and 300mm
manufacturing, on November 30, 2007, the Company terminated
its product purchase agreement with Infineon for the production
of wafers at DD200. As a result of the termination, the Company
accrued restructuring costs of 12 during the three months
ended December 31, 2007 for amounts to be reimbursed to
Infineon for costs related to one DD200 module. In
addition, included in cost of sales are 17 related to
purchase commitments for 200mm wafer contract manufacturing at
Infineon Dresden. Additionally, the companies are presently
discussing additional reimbursement from the Company for idle
costs of approximately 20 which have not been incurred or
accrued as of December 31, 2007.
Burlington
Development Center
Due to continued efforts to improve cost and efficiency, in
December 2007, the Company announced plans to consolidate its
U.S. research and development facilities in a single
development center located in Raleigh, North Carolina. As a
result, the Companys development center in Burlington,
Vermont, is to be closed at the end of June 2008. The Company
accrued restructuring costs of 4 during the three months
ended December 31, 2007 for lease termination costs and
severance payments related to approximately 100 employees.
Income tax expense for the three months ended December 31,
2006 and 2007 is as follows:
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Continuing operations:
|
|
|
|
|
|
|
Current taxes
|
|
|
(64)
|
|
|
(8)
|
Deferred taxes
|
|
|
(10)
|
|
|
(1)
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
(74)
|
|
|
(9)
|
|
|
|
|
|
|
|
Other comprehensive (income) loss (note 12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
29%
|
|
|
(2)%
|
|
|
|
|
|
|
|
On August 17, 2007 the Business Tax Reform Act of 2008 was
enacted in Germany. This bill introduces several changes to the
taxation of German business activities, including a reduction of
the combined corporate and trade tax rate in Germany from
approximately 39% to 30%. Most of the changes apply to the
Company from October 1, 2007 and affect the Companys
current tax rate from that date.
In each of the three months ended December 31, 2006 and
2007, our effective tax rate was lower than the combined German
statutory tax rate of 39% and 30%, respectively. This resulted
mainly from income in jurisdictions with lower than average
corporate tax rates, tax credits, and in the three months ended
December 31, 2007 additional valuation allowances against
current period tax benefits.
Pursuant to SFAS No. 109, the Company has assessed its
deferred tax asset and the need for a valuation allowance. The
assessment was based on the benefits that could be realized from
available tax strategies, forecasted future taxable income to
the extent applicable, and the reversal of temporary differences
in future periods. As a result of this assessment, the Company
increased its deferred tax asset valuation allowance as of
December 31, 2007 to reduce the deferred tax asset to an
amount that is more likely than not expected to be realized in
future.
Despite the consolidated pretax loss, the Company generated
taxable income in certain tax jurisdictions which resulted in
the negative effective tax rate during the three months ended
December 31, 2007.
16
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
Adoption of
FIN 48
The Company adopted FIN 48, and related guidance on
October 1, 2007. FIN 48 clarifies the accounting and
reporting for uncertainties in income tax law. FIN 48
prescribes a comprehensive model for the financial statement
recognition, measurement, presentation and disclosure of
uncertain tax positions taken or expected to be taken in income
tax returns. FIN 48 contains a two-step approach to
recognizing and measuring uncertain tax positions accounted for
in accordance with SFAS No. 109. The first step is to
evaluate the tax position for recognition by determining if the
weight of available evidence indicates that it is more likely
than not that the position will be sustained on audit, including
resolution of any related appeals or litigation processes. The
second step is to measure the tax benefit as the largest amount
that is more than 50% likely of being realized upon ultimate
settlement.
The adoption of FIN 48 as of October 1, 2007 did not
affect the Companys liability for unrecognized tax
benefits. The total amount of gross unrecognized tax benefits as
of the date of adoption was 37 which, if recognized, would
favorably affect the Companys effective tax rate. Interest
and penalties related to income tax liabilities are classified
as interest expense. The Company had no significant accrued
interest and penalties recorded as of the date of adoption.
During the three months ended December 31, 2007 the total
amount of unrecognized tax benefits was as follows:
|
|
|
|
|
|
Three months ended
|
|
|
December 31, 2007
|
|
unrecognized tax benefits at beginning of period
|
|
|
37
|
Increase in unrecognized tax benefits
|
|
|
8
|
|
|
|
|
unrecognized tax benefits at end of period
|
|
|
45
|
|
|
|
|
The Company does not expect significant changes in the total
amount of unrecognized tax benefits through September 30,
2008. As of the date of adoption, the Companys tax returns
since the Formation remain subject to examination in the
majority of tax jurisdictions.
|
|
5.
|
Earnings (Loss)
Per Share
|
Basic earnings (loss) per share (EPS) are calculated
by dividing net income (loss) by the weighted average number of
ordinary shares outstanding during the three months ended
December 31, 2006 and 2007.
On November 24, 2006, the Company granted 1.9 million
stock options pursuant to the Qimonda Stock Option Plan
(note 11). None of these options were dilutive to EPS for
the three months ended December 31, 2006 and 2007. The
Company accounts for the potentially dilutive effects of its
stock options according to the provisions of
SFAS No. 123(R).
The computation of basic and diluted EPS for the three months
ended December 31, 2006 and 2007 is as follows:
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Numerator Income (loss) available to ordinary
shareholders, basic and diluted
|
|
|
177
|
|
|
(598
|
)
|
Denominator Weighted-average shares outstanding,
basic and diluted
|
|
|
342,000,000
|
|
|
342,000,001
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share (in euro):
|
|
|
|
|
|
|
|
Basic and diluted
|
|
|
0.52
|
|
|
(1.75
|
)
|
17
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
|
|
6.
|
Trade Accounts
Receivable, net
|
Trade accounts receivable at September 30, 2007 and
December 31, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Third party trade
|
|
|
333
|
|
|
|
254
|
|
Infineon group trade (note 14)
|
|
|
11
|
|
|
|
7
|
|
Associated and Related Companies trade (note 14)
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable, gross
|
|
|
347
|
|
|
|
264
|
|
Allowance for doubtful accounts
|
|
|
(6
|
)
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable, net
|
|
|
341
|
|
|
|
258
|
|
|
|
|
|
|
|
|
|
|
Inventories at September 30, 2007 and December 31,
2007 consist of the following:
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Raw materials and supplies
|
|
|
63
|
|
|
53
|
Work-in-process
|
|
|
311
|
|
|
180
|
Finished goods
|
|
|
245
|
|
|
153
|
|
|
|
|
|
|
|
Total inventories
|
|
|
619
|
|
|
386
|
|
|
|
|
|
|
|
On August 20, 2007, Inotera issued 40 million common
shares, representing 1.2% of its outstanding share capital, as
bonuses to its employees, which diluted the Companys
ownership interest to 35.6%. The Company recorded the related
dilution loss of 7 as part of non-operating expense during
the three months ended December 31, 2007.
In connection with the Formation, Infineon and Qimonda entered
into a trust agreement under which Infineon placed the Inotera
shares in trust for the Company until the shares could legally
be transferred. In March 2007, the Inotera shares (except for a
portion representing less than 1% of the total shares) were
transferred to Qimonda. The Inotera shares remain subject to
Taiwanese
lock-up
provisions related to the Inotera IPO through January 2008,
after which the remaining less than 1% of the shares are to be
transferred to Qimonda. Qimonda expects the final transfer to
occur during the current financial year ending
September 30, 2008.
During the three months ended December 31, 2007 Sony
Corporation and Qimonda AG established the Qreatic Design joint
venture. The scope of the joint venture is the design of
high-performance, low power, embedded and customer specific
DRAMs for consumer and graphic applications. According to the
agreement, the 50:50 joint venture started with specialists from
Sony and Qimonda, bringing together their engineering expertise
for the mutual benefit of both companies. Qreatic Design, which
is located in Tokyo, Japan, started operations during the three
months ended December 31, 2007. The Company accounts for
its investment in Qreatic Design using the equity method of
accounting due to the lack of unilateral control.
18
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
|
|
9.
|
Trade Accounts
Payable
|
Trade accounts payable at September 30, 2007 and
December 31, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Third party trade
|
|
|
601
|
|
|
572
|
Infineon group trade (note 14)
|
|
|
56
|
|
|
56
|
Associated and Related Companies trade (note 14)
|
|
|
99
|
|
|
76
|
|
|
|
|
|
|
|
Total
|
|
|
756
|
|
|
704
|
|
|
|
|
|
|
|
Debt at September 30, 2007 and December 31, 2007
consists of the following:
|
|
|
|
|
|
|
|
|
as of
|
|
as of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Short-term debt and current maturities:
|
|
|
|
|
|
|
Notes payable to banks, rate 6.09%
|
|
|
28
|
|
|
|
Current portion of long term debt, rate 5.19%
|
|
|
21
|
|
|
21
|
Capital lease obligation
|
|
|
28
|
|
|
47
|
|
|
|
|
|
|
|
Total short-term debt and current maturities
|
|
|
77
|
|
|
68
|
|
|
|
|
|
|
|
Long-term debt:
|
|
|
|
|
|
|
Unsecured term bank loan, rate 5.19%, due 2013
|
|
|
103
|
|
|
103
|
Notes payable to governmental entity, rate 5.06%, due 2027
|
|
|
24
|
|
|
23
|
Capital lease obligation
|
|
|
100
|
|
|
178
|
|
|
|
|
|
|
|
Total long-term debt
|
|
|
227
|
|
|
304
|
|
|
|
|
|
|
|
In September 2007, the Company entered into a four year sale and
leaseback transaction of 200mm equipment in its Richmond
facility. In December 2007, the Company entered into an
additional four year sale and leaseback transaction of 200mm
equipment and a five year sale and leaseback transaction of
300mm equipment, both at Richmond. The leases are accounted for
as capital leases whereby the present values of the respective
lease payments are reflected as capital lease obligations.
The Company can also draw, for short term purposes, on the
working capital lines it maintains in several locations with an
aggregate amount of 228 as of December 31, 2007. In
October 2007 the Company fully repaid 28 short-term notes
payable to banks which had been drawn as of September 30,
2007 for working capital purposes.
Aggregated amounts of debt, including capital lease obligations,
maturing subsequent to December 31, 2007 are as follows:
|
|
|
|
Year ending September 30,
|
|
Amount
|
|
2008
|
|
|
68
|
2009
|
|
|
74
|
2010
|
|
|
78
|
2011
|
|
|
71
|
2012
|
|
|
37
|
Thereafter
|
|
|
44
|
|
|
|
|
Total debt
|
|
|
372
|
|
|
|
|
19
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
|
|
11.
|
Stock-based
Compensation
|
A summary of the status of the Qimonda stock option plan 2006 as
of December 31, 2007, and changes during the three months
then ended is presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
average
|
|
Weighted
|
|
|
Number of
|
|
Weighted-
|
|
remaining
|
|
average
|
|
|
options in
|
|
average
|
|
contractual life
|
|
grant date
|
|
|
million
|
|
exercise price
|
|
(in years)
|
|
fair value
|
|
Outstanding at beginning of period
|
|
|
1.9
|
|
$
|
15.97
|
|
|
5.16
|
|
$
|
4.23
|
Granted
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited and expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period
|
|
|
1.9
|
|
$
|
15.97
|
|
|
4.91
|
|
$
|
4.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested during the period
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected to ultimately vest at end of period
|
|
|
1.7
|
|
$
|
15.97
|
|
|
4.91
|
|
$
|
4.23
|
Exercisable at end of period
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-Based
Compensation Expense
Stock-based compensation expenses for the Infineon and the
Qimonda SOP were allocated as follows for the three months ended
December 31, 2006 and 2007:
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Compensation expense recognized:
|
|
|
|
|
|
|
Cost of sales
|
|
|
1
|
|
|
1
|
Selling, general and administrative expenses
|
|
|
1
|
|
|
|
Research and development expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense
|
|
|
2
|
|
|
1
|
|
|
|
|
|
|
|
Related to:
|
|
|
|
|
|
|
Infineon Stock Options:
|
|
|
2
|
|
|
1
|
Qimonda Stock Options:
|
|
|
|
|
|
|
The amount of stock-based compensation cost which was
capitalized and remained in inventories during the three months
ended December 31, 2006 and 2007 was immaterial.
Stock-based compensation expense does not reflect income tax
benefits, since stock options are primarily granted in tax
jurisdictions where the expense is not deductible for tax
purposes. In addition, stock-based compensation expense did not
have a cash flow effect during the three months ended
December 31, 2007, since no exercises of stock options
occurred during the period. As of December 31, 2007, for
Infineon related stock options there was a total of 2 in
unrecognized compensation expense related to unvested stock
options which is expected to be recognized over a remaining
total period of 2.25 years, and for Qimonda related stock
options there was a total of 4 in unrecognized
compensation expense related to unvested stock options which is
expected to be recognized over a remaining total period of
2.02 years.
Options on Infineon stock do not represent potential dilutive
instruments for Qimonda AG and accordingly, they have no
dilutive impact on diluted EPS (note 5). The Qimonda stock
options were not dilutive to EPS for the three months ended
December 31, 2007 (note 5).
20
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
The changes in the components of other comprehensive income
(loss) for the three months ended December 31, 2006 and
2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
|
|
|
Tax
|
|
|
|
|
|
Tax
|
|
|
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Pretax
|
|
Effect
|
|
Net
|
|
Accumulated other comprehensive (loss) income
beginning of period
|
|
|
(136
|
)
|
|
|
2
|
|
|
(134
|
)
|
|
|
(257
|
)
|
|
|
(2
|
)
|
|
|
(259
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Unrealized losses on securities, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
(2
|
)
|
*Additional minimum pension liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Foreign currency translation adjustment
|
|
|
(54
|
)
|
|
|
|
|
|
(54
|
)
|
|
|
(45
|
)
|
|
|
|
|
|
|
(45
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss
|
|
|
(54
|
)
|
|
|
|
|
|
(54
|
)
|
|
|
(47
|
)
|
|
|
|
|
|
|
(47
|
)
|
Accumulated other comprehensive (loss) income end of
period
|
|
|
(190
|
)
|
|
|
2
|
|
|
(188
|
)
|
|
|
304
|
|
|
|
(2
|
)
|
|
|
(306
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thereof:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Unrealized losses on securities, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8
|
)
|
|
|
|
|
|
|
(8
|
)
|
*Additional minimum pension liability
|
|
|
(4
|
)
|
|
|
2
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
*Foreign currency translation adjustment
|
|
|
(186
|
)
|
|
|
|
|
|
(186
|
)
|
|
|
(301
|
)
|
|
|
|
|
|
|
(301
|
)
|
*Pension net actuarial gain (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
(3
|
)
|
|
|
6
|
|
*Pension net prior service credit (cost)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
1
|
|
|
|
(3
|
)
|
Total comprehensive income (loss) for the three months ended
December 31, 2006 and 2007 was as follows:
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Net income (loss)
|
|
|
177
|
|
|
|
(598
|
)
|
Other comprehensive loss
|
|
|
(54
|
)
|
|
|
(47
|
)
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
123
|
|
|
|
(645
|
)
|
|
|
|
|
|
|
|
|
|
|
|
13.
|
Supplemental Cash
Flow Information
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Cash paid for:
|
|
|
|
|
|
|
Interest to third parties
|
|
|
10
|
|
|
4
|
Income taxes
|
|
|
12
|
|
|
1
|
Non-cash financing activities:
|
|
|
|
|
|
|
Capital lease obligation (note 10)
|
|
|
|
|
|
108
|
The Company has transactions in the normal course of business
with Infineon group companies and with Related and Associated
Companies (together, Related Parties). The Company
purchases certain of
21
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
its raw materials, especially chipsets, from, and sells certain
of its products to, Related Parties. Purchases and sales to
Related Parties are generally based on market prices or
manufacturing cost plus a
mark-up.
Related Party receivables as of September 30, 2007 and
December 31, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Current:
|
|
|
|
|
|
|
Infineon group trade (note 6)
|
|
|
11
|
|
|
7
|
Associated and Related Companies trade (note 6)
|
|
|
3
|
|
|
3
|
Associated and Related Companies financial and other
|
|
|
2
|
|
|
2
|
Employee receivables
|
|
|
3
|
|
|
1
|
|
|
|
|
|
|
|
Total Related Party receivables
|
|
|
19
|
|
|
13
|
|
|
|
|
|
|
|
Related Party payables as of September 30, 2007 and
December 31, 2007 consist of the following:
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Current:
|
|
|
|
|
|
|
Infineon group trade (note 9)
|
|
|
56
|
|
|
56
|
Associated and Related Companies trade (note 9)
|
|
|
99
|
|
|
76
|
|
|
|
|
|
|
|
Total Related Party payables
|
|
|
155
|
|
|
132
|
|
|
|
|
|
|
|
Related Party receivables and payables have been segregated
first between amounts owed by or to Infineon group companies and
companies in which the Company has an ownership interest, and
second based on the underlying nature of the transactions. Trade
receivables and payables include amounts for the purchase and
sale of products and services. Financial and other receivables
and payables represent amounts owed relating to loans and
advances and accrued interest at interbank rates.
Transactions with Related Parties during the three months ended
December 31, 2006 and 2007 include the following:
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Purchases from Related Parties:
|
|
|
|
|
|
|
Infineon group companies
|
|
|
98
|
|
|
63
|
Associated and Related Companies
|
|
|
137
|
|
|
103
|
|
|
|
|
|
|
|
|
|
|
235
|
|
|
166
|
|
|
|
|
|
|
|
Interest expense to Infineon group companies
|
|
|
5
|
|
|
|
Purchases from Infineon during the three months ended
December 31, 2006 and 2007 are principally related to
products purchased from the DD200 facility and are based on
Infineons cost plus a margin.
Since the Formation, the Company entered into several service
agreements with Infineon. These include general support services
(including sales support, logistics services, purchasing
services, human resources services, facility management
services, patent support, finance, accounting and treasury
support, legal services and strategy services), R&D
services and IT services. Transactions under these agreements
during the three months ended December 31, 2006 and 2007
are included in purchases from Infineon (see above) and
reflected in the consolidated statements of operations as
follows:
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Cost of goods sold
|
|
|
4
|
|
|
5
|
Research and development expenses
|
|
|
10
|
|
|
6
|
Selling, general and administrative expenses
|
|
|
5
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
15
|
|
|
|
|
|
|
|
22
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
In connection with the Formation, the Company entered into a
global service agreement with Infineon, whereby the parties
intend to provide standard support services to one another based
on actual costs plus a margin of 3%. The Company and Infineon
have also entered into a research and development services
agreement for the provision of research and development services
between the parties based on actual cost plus a margin of 3%.
Under the master information technology cost sharing agreement,
Infineon and the Company generally agree to share costs of a
variety of information technology services provided by one or
both parties in the common interest and for the common benefit
of both parties. In general, the parties agree to share the
fixed costs of the services provided (accounting for
approximately 53% of total costs) roughly equally and to share
variable costs in a manner that reflects each partys
contribution to those costs. Under the master information
technology service agreement, Infineon and the Company agree to
provide information technology services to one another. In
general, under all of these agreements, the service recipient
pays a fee based on actual or estimated total costs incurred
plus a margin of 3% for the period from May 1, 2006 to
September 30, 2008 and thereafter as mutually agreed from
year to year.
The components of net periodic pension cost (NPPC)
for the three months ended December 31, 2006 and 2007 are
presented as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
|
Domestic
|
|
Foreign
|
|
Domestic
|
|
Foreign
|
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Plans
|
|
Service cost
|
|
|
(1
|
)
|
|
|
|
|
|
(1
|
)
|
|
|
|
Interest cost
|
|
|
(1
|
)
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NPPC
|
|
|
(2
|
)
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qimonda contributed 1 and 0, respectively, to fund
its pension plans during the three months ended
December 31, 2006 and 2007.
|
|
16.
|
Financial
Instruments
|
The Company periodically enters into financial instruments,
including foreign currency forward contracts. The objective of
these transactions is to reduce the impact of exchange rate
fluctuations on the Companys foreign currency denominated
net future cash flows. The Company does not enter into
derivatives for trading or speculative purposes.
The euro equivalent notional amounts in millions and fair values
of the Companys derivative instruments as of
September 30, 2007 and December 31, 2007 are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2007
|
|
As of December 31, 2007
|
|
|
Notional
|
|
Fair
|
|
Notional
|
|
Fair
|
|
|
amount
|
|
value
|
|
amount
|
|
value
|
|
Forward contracts sold:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar
|
|
|
475
|
|
|
11
|
|
|
|
392
|
|
|
(5
|
)
|
Japanese yen
|
|
|
2
|
|
|
|
|
|
|
1
|
|
|
|
|
Forward contracts purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. dollar
|
|
|
72
|
|
|
(1
|
)
|
|
|
45
|
|
|
|
|
Japanese yen
|
|
|
70
|
|
|
(2
|
)
|
|
|
72
|
|
|
(1
|
)
|
Singapore dollar
|
|
|
5
|
|
|
|
|
|
|
5
|
|
|
|
|
Malaysian ringgit
|
|
|
17
|
|
|
|
|
|
|
12
|
|
|
|
|
Other currencies
|
|
|
1
|
|
|
|
|
|
|
15
|
|
|
|
|
Other
|
|
|
108
|
|
|
11
|
|
|
|
109
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value, net
|
|
|
|
|
|
19
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
Gains and losses from foreign currency derivatives and
transactions are principally included in cost of goods sold, and
were as follows for the three months ended December 31,
2006 and 2007:
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
Three months ended
|
|
|
December 31, 2006
|
|
|
December 31, 2007
|
|
Net (losses) gains from foreign currency derivatives and
transactions
|
|
|
(11
|
)
|
|
|
3
|
|
|
17.
|
Commitments and
Contingencies
|
Contribution
from Infineon
These contingencies described below were assigned to the Company
pursuant to the contribution agreement entered into between
Infineon and the Company in connection with the Formation.
Under the contribution agreement, the Company is required to
indemnify Infineon, in whole or in part as specified below, for
any claim (including any related expenses) arising in connection
with the liabilities, contracts, offers, uncompleted
transactions, continuing obligations, risks, encumbrances and
other liabilities Infineon incurs in connection with the matters
described below.
The contribution agreement is based on the principle that all
potential liabilities and risks in connection with legal matters
existing as of the Formation date are generally to be borne by
the business unit which caused the risk or liability or where
the risk or liability arose. Except to the limited extent
described below for the securities class action litigation and
the settled Tessera litigation (for which the Company has
different arrangements), the Company has agreed to indemnify
Infineon for all liabilities arising in connection with all
legal matters specifically described below, including court
costs and legal fees. Infineon will not settle or otherwise
agree to any of these liabilities without the Companys
prior consent. Liabilities and risks relating to the securities
class action litigation, including court costs, will be equally
shared by Infineon and the Company, but only with respect to the
amount by which the total amount payable exceeds the amount of
the corresponding accrued liability that Infineon transferred to
the Company at the Formation. Infineon has agreed not to settle
this lawsuit without the Companys prior consent. Any
expenses incurred in connection with the assertion of claims
against the provider of directors and officers
(D & O) insurance covering Infineons two
current or former officers named as defendants in the suit will
also be equally shared. The D & O insurance provider
has so far refused coverage. The Company has agreed to indemnify
Infineon for 80% of the court costs and legal fees relating to
the settled litigation with Tessera.
The Company has further agreed to pay 60% of the total license
fees payable by Infineon and the Company to which Infineon and
the Company may agree in connection with two cases in which
negotiations relating to licensing and cross-licensing were
ongoing at the time of the Formation, one of which is still
ongoing.
In accordance with the general principle that all potential
risks or liabilities are to be borne by the entity which caused
the risk or liability or where the risk or liability arose, the
indemnification provisions of the contribution agreement include
the following specific provisions with respect to claims or
lawsuits arising after the Formation:
|
|
|
|
|
liabilities arising in connection with intellectual property
infringement claims relating to memory products are to be borne
by the Company.
|
|
|
|
liabilities arising in connection with actual or alleged
antitrust violations with respect to DRAM products are to be
borne by the Company.
|
Litigation
In September 2004, Infineon entered into a plea agreement with
the Antitrust Division of the U.S. Department of Justice
(DOJ) in connection with its ongoing investigation
of alleged antitrust violations in the DRAM industry. Pursuant
to this plea agreement, Infineon agreed to plead guilty to a
single count related to the pricing of DRAM between July 1,
1999 and June 15, 2002, and to pay a fine of
$160 million. The fine plus accrued interest is to be paid
in equal annual installments through 2009. On October 25,
2004, the plea agreement was accepted by the U.S. District
Court for the Northern District of California. Therefore, the
matter has been fully resolved as between Infineon and the DOJ,
subject to
24
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
Infineons obligation to cooperate with the DOJ in its
ongoing investigation of other participants in the DRAM
industry. The charges by the DOJ related to DRAM-product sales
to six Original Equipment Manufacturer (OEM)
customers that manufacture computers and servers. Infineon has
entered into settlement agreements with five of these OEM
customers and is considering the possibility of a settlement
with the remaining OEM customer, which purchased only a very
small volume of DRAM from Infineon.
Subsequent to the commencement of the DOJ investigation, a
number of purported class action lawsuits were filed against
Infineon, its principal U.S. subsidiary and other DRAM
suppliers.
Sixteen cases were filed between June 2002 and September 2002 in
several U.S. federal district courts purporting to be on
behalf of a class of individuals and entities who purchased DRAM
directly from various DRAM suppliers in the U.S. during a
specified time period (Direct U.S. Purchaser
Class), alleging price-fixing in violation of the Sherman
Act and seeking treble damages in unspecified amounts, costs,
attorneys fees, and an injunction against the allegedly
unlawful conduct.
In September 2002, the Judicial Panel on Multi-District
Litigation ordered that the foregoing federal cases be
transferred to the U.S. District Court for the Northern
District of California for coordinated or consolidated pre-trial
proceedings as part of a Multi-District Litigation
(MDL). In June 2006, the court issued an order
certifying a direct purchaser class.
In September 2005, Infineon and its principal
U.S. subsidiary entered into a definitive settlement
agreement with counsel to the Direct U.S. Purchaser Class
(granting an opportunity for individual class members to opt out
of the settlement). The settlement agreement was approved by the
court on November 1, 2006 and the court entered final
judgment and dismissed the class action claims with prejudice on
November 2, 2006. Under the terms of the settlement
agreement Infineon agreed to pay approximately $21 million.
In addition to this settlement payment, Infineon agreed to pay
an additional amount if it is proven that sales of DRAM products
to the settlement class after opt-outs during the settlement
period exceeded $208.1 million. The Company would also be
responsible for this payment. The additional amount payable is
calculated by multiplying the amount by which these sales exceed
$208.1 million by 10.53%. The Company does not currently
expect to pay any additional amount to the class. The Company
has reached individual settlements with eight direct customers
in addition to those OEMs identified by the DOJ.
In April 2006, Unisys Corporation filed a complaint against
Infineon and its principal U.S. subsidiary, among other
DRAM suppliers, alleging state and federal claims for price
fixing and seeking recovery as both a direct and indirect
purchaser of DRAM. On May 5, 2006, Honeywell International,
Inc. filed a complaint against Infineon and its
U.S. subsidiary, among other DRAM suppliers, alleging a
claim for price fixing under federal law, and seeking recovery
as a direct purchaser of DRAM. Both of these complaints were
filed in the Northern District of California, and have been
related to the MDL described above. Both Unisys and Honeywell
opted out of the Direct U.S. Purchaser Class and
settlement, so their claims are not barred by Infineons
settlement with the Direct U.S. Purchaser Class. On
April 5, 2007 the court dismissed Unisys initial
complaint with leave to amend for failing to give proper notice
of its claims. Unisys filed a First Amended Complaint on
May 4, 2007. Infineon, its principal U.S. subsidiary,
and the other defendants again filed a motion to dismiss certain
portions of the Unisys First Amended Complaint on June 4,
2007. After Honeywell had filed a stipulation of dismissal
without prejudice of its lawsuit against Infineon, the court
entered the dismissal order on April 26, 2007. Between
February 28, 2007 and March 8, 2007 four more opt-out
cases were filed by All American Semiconductor, Inc., Edge
Electronics, Inc., Jaco Electronics, Inc. and DRAM Claims
Liquidation Trust, by its Trustee, Wells Fargo Bank, N.A. The
All American Semiconductor complaint alleges claims for
price-fixing under the Sherman Act. The Edge Electronics, Jaco
Electronics and DRAM Claims Liquidation Trust complaints allege
state and federal claims for price-fixing. As with Unisys and
Honeywell, the claims of these plaintiffs are not barred by
Infineons settlement with the Direct U.S. Purchaser
Class, since they opted out of the Direct U.S. Purchaser
Class and settlement. All four of these opt-out cases were filed
in the Northern District of California and have been related to
the MDL described above. Based upon the Courts order
dismissing portions of the initial Unisys complaint above, the
plaintiffs in all four of these opt-out cases filed amended
complaints on May 4, 2007. On June 4, 2007, Infineon
and its principal U.S. subsidiary answered the amended
complaints filed by All American Semiconductor, Inc., Edge
Electronics, Inc., and Jaco Electronics, Inc. Also on
June 4, 2007, Infineon and its principal
U.S. subsidiary, along with its co-defendants filed joint
motions to dismiss certain portions of
25
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
the DRAM Claims Liquidation Trust and Unisys amended complaint.
On October 15, 2007 the Court denied the motion to dismiss
the Unisys amended complaint and deferred ruling on the motion
to dismiss the DRAM Claims Liquidation Trust complaint. On
October 29, 2007, Infineon and its principal U.S.
subsidiary answered the amended complaints of Unisys and DRAM
Claims Liquidations Trust. Discovery in all of the cases closed
on December 17, 2007. The court has scheduled a trial date
for June 1, 2009.
Sixty-four additional cases were filed between August 2002 and
October 2005 in numerous federal and state courts throughout the
United States of America. Each of these state and federal cases
(except a case filed in the U.S. District Court for the
Eastern District of Pennsylvania in May 2005 on behalf of
foreign purchasers) purports to be on behalf of a class of
individuals and entities who indirectly purchased DRAM in the
U.S. during specified time periods commencing in or after
1999. The complaints variously allege violations of the Sherman
Act, Californias Cartwright Act, various other state laws,
unfair competition law and unjust enrichment and seek treble
damages in generally unspecified amounts, restitution, costs,
attorneys fees and an injunction against the allegedly
unlawful conduct.
Twenty-three of the state (outside California) and federal court
cases and the U.S. District Court for the Eastern District
of Pennsylvania case were ordered transferred to the
U.S. District Court for the Northern District of California
for coordinated and consolidated pre-trial proceedings as part
of the MDL described above. After this transfer, the plaintiffs
dismissed two of the transferred cases. Two additional
transferred cases were subsequently remanded back to their
relevant state courts. Nineteen of the twenty-three transferred
cases are currently pending in the MDL-litigation. The Eastern
District of Pennsylvania case purporting to be on behalf of a
class of foreign individuals and entities who directly purchased
DRAM outside of the United States of America from July 1999
through at least June 2002, was dismissed with prejudice and
without leave to amend in March 2006. Plaintiffs in that case
have filed a notice of appeal. In July 2006, plaintiffs filed
their opening brief on appeal, and defendants filed their joint
opening brief in September 2006. No hearing date has yet been
scheduled for the appeal. The California state cases were
ordered transferred for coordinated and consolidated pre-trial
proceedings to the San Francisco County Superior Court. The
plaintiffs in the indirect purchaser cases that originated
outside California which have not been transferred to the MDL
agreed to stay proceedings in those cases pending resolution of
the MDL pretrial-proceedings through a single complaint on
behalf of a putative nationwide class of indirect purchasers in
the MDL. The defendants filed two motions for judgment on the
pleadings directed at several of the claims in the indirect
purchaser case pending in the MDL. The court entered an order on
June 1, 2007 granting in part and denying in part the
defendants motions. The order dismissed a large percentage
of the indirect purchaser plaintiffs claims, and granted
leave to amend with regard to claims under three specific state
statutes. The court ruled that the indirect purchaser plaintiffs
must file a motion for leave to amend the complaint with regard
to any of the other dismissed claims. On June 29, 2007, the
indirect plaintiffs filed both a First Amended Complaint, and a
motion for leave to file a Second Amended Complaint that
attempted to resurrect some of the claims that were dismissed.
On August 17, 2007, the court entered an order granting the
motion to file the Second Amended Complaint, which repleaded
part of the previously dismissed claims. On October 1,
2007, the defendants filed another motion to dismiss directed at
many of the same claims that were previously dismissed in the
courts June 1, 2007 order. A hearing was held on this
motion for judgment on the pleadings on December 12, 2007.
The indirect plaintiffs motion for class certification was
filed on July 10, 2007, and defendants filed a joint
opposition to that motion on September 28, 2007. However,
on December 5, 2007 the court issued an order vacating the
current motion for class certification until the court ruled on
the motion to dismiss (Note 19).
In July 2006, the New York state attorney general filed an
action in the U.S. District Court for the Southern District
of New York against Infineon, its principal U.S. subsidiary
and several other DRAM manufacturers on behalf of New York
governmental entities and New York consumers who purchased
products containing DRAM beginning in 1998. The plaintiffs
allege violations of state and federal antitrust laws arising
out of the same allegations of DRAM price-fixing and artificial
price inflation practices discussed above, and seek recovery of
actual and treble damages in unspecified amounts, penalties,
costs (including attorneys fees) and injunctive and other
equitable relief. On October 23, 2006, the New York
case was transferred to the Northern District of California and
made part of the MDL proceedings. In July 2006, the attorneys
general of California, Alaska, Arizona, Arkansas, Colorado,
Delaware, Florida, Hawaii, Idaho, Illinois, Iowa, Louisiana,
Maryland, Massachusetts, Michigan,
26
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
Minnesota, Mississippi, Nebraska, Nevada, New Mexico, North
Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina,
Tennessee, Texas, Utah, Vermont, Virginia, Washington, West
Virginia and Wisconsin filed a lawsuit in the U.S. District
Court for the Northern District of California against Infineon,
its principal U.S. subsidiary and several other DRAM
manufacturers on behalf of governmental entities, consumers and
businesses in each of those states who purchased products
containing DRAM beginning in 1998. On September 8, 2006,
the complaint was amended to add claims by the attorneys general
of Kentucky, Maine, New Hampshire, North Carolina, the Northern
Mariana Islands and Rhode Island. This action is based on state
and federal law claims relating to the same alleged
anticompetitive practices in the sale of DRAM and plaintiffs
seek recovery of actual and treble damages in unspecified
amounts, penalties, costs (including attorneys fees) and
injunctive and other relief. On October 10, 2006 Infineon
joined the other defendants in filing motions to dismiss several
of the claims alleged in these two actions. A hearing on these
motions was heard on February 7, 2007. On August 31,
2007, the court entered orders granting the motions in part and
denying the motions in part. The courts order dismissed
the claims on behalf of consumers, businesses and governmental
entities in a number of states, and dismissed certain other
claims with leave to amend, with any amended complaints to be
filed by October 1, 2007. Amended complaints in both
actions were filed on October 1, 2007. On November 26,
2007 Infineon joined the other defendants in filing motions to
dismiss several of the claims alleged in these amended
complaints. A hearing is scheduled for these motions on
February 27, 2008. Plaintiffs California and New Mexico
filed a joint motion for class certification seeking to certify
classes of all public entities within both states. A hearing on
the motion for class certification has been scheduled for
March 12, 2008. Between June 25, 2007 and
August 15, 2007, the attorneys general of four states,
Alaska, New Hampshire, Ohio and Texas, filed requests for
dismissal of their claims without prejudice.
In April 2003, Infineon received a request for information from
the European Commission (the Commission) to enable
the Commission to assess the compatibility with the
Commissions rules on competition of certain practices of
which the Commission has become aware in the European market for
DRAM products. Infineon reassessed the matter after its plea
agreement with the DOJ and made an accrual during the 2004
financial year for a probable minimum fine that may be imposed
as a result of the Commissions investigation. Any fine
actually imposed by the Commission may be significantly higher
than the reserve established, although Infineon cannot more
accurately estimate the amount of such actual fine. Infineon is
fully cooperating with the Commission in its investigation.
In May 2004, the Canadian Competition Bureau advised
Infineons principal U.S. subsidiary that it and its
affiliated companies are among the targets of a formal inquiry
into alleged violations of the Canadian Competition Act. No
compulsory process (such as subpoenas) has commenced. Infineon
is cooperating with the Competition Bureau in its inquiry.
Between December 2004 and February 2005, two putative class
proceedings were filed in the Canadian province of Quebec and
one was filed in each of Ontario and British Columbia against
Infineon, its principal U.S. subsidiary and other DRAM
manufacturers on behalf of all direct and indirect purchasers
resident in Canada who purchased DRAM or products containing
DRAM between July 1999 and June 2002, seeking damages,
investigation and administration costs, as well as interest and
legal costs. Plaintiffs primarily allege conspiracy to unduly
restrain competition and to illegally fix the price of DRAM. In
the British Columbia action, two hearings on the certificate
motion took place in August 2007 and in November 2007. In one
Quebec class action, a tentative date for the motion for
authorization (certification) has been set for May 2008 (with
some possibility of a March 2008 date if the court calendar
opens); the other Quebec action has been stayed pending
developments in the one that is going forward.
Between September 2004 and November 2004, seven securities class
action complaints were filed against Infineon and three of its
current or former officers (of which one officer was
subsequently dropped as a defendant) in the U.S. District
Courts for the Northern District of California and the Southern
District of New York. The plaintiffs voluntarily dismissed the
New York cases, and in June 2005 filed a consolidated amended
complaint in California on behalf of a putative class of
purchasers of Infineons publicly-traded securities, who
purchased them during the period between March, 2000 and July
2004, effectively combining all lawsuits. The consolidated
amended complaint added Infineons principal
U.S. subsidiary and four then-current or former employees
of Infineon and its affiliate as defendants. It alleges
violations of the U.S. securities laws and asserts that the
defendants made materially false and misleading public
27
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
statements about Infineons historical and projected
financial results and competitive position because they did not
disclose Infineons alleged participation in DRAM
price-fixing activities and that, by fixing the price of DRAM,
defendants manipulated the price of Infineons securities,
thereby injuring its shareholders. The plaintiffs seek
unspecified compensatory damages, interest, costs and
attorneys fees. In September 2006, the court dismissed the
complaint with leave to amend and in October 2006 the plaintiffs
filed a second amended complaint. In March 2007, pursuant to a
stipulation agreed with the defendants, the plaintiffs withdrew
the second amended complaint and were granted a motion for leave
to file a third amended complaint. The plaintiffs filed a third
amended complaint on July 17, 2007. A hearing was held on
November 19, 2007 (Note 19). In the contribution agreement
the Company entered into with Infineon, the Company agreed to
share any future liabilities arising out of this lawsuit equally
with Infineon, including the cost of defending the suit.
Infineon believes these claims are without merit. The Company is
currently unable to provide an estimate of the likelihood of an
unfavorable outcome to Infineon or of the amount or range of
potential loss arising from these actions. If the outcome of
these actions is unfavorable or if Infineon incurs substantial
legal fees in defending these actions regardless of outcome, it
may have a material adverse effect on the Companys
financial condition and results of operations. Infineons
directors and officers insurance carriers have
denied coverage in the securities class actions and Infineon
filed suits against the carriers in December 2005 and August
2006. Infineons claims against one D&O insurance
carrier were finally dismissed in May 2007. The claims against
the other insurance carrier are still pending.
On April 10, 2007, Lin Packaging Technologies, Ltd. (Lin)
filed a lawsuit against Infineon, its principal
U.S. subsidiary and an additional DRAM manufacturer in the
U.S. District Court for the Eastern District of Texas,
alleging that certain DRAM products were infringing two Lin
patents. In May 2007, Lin amended its complaint to include
Qimonda AG, Qimonda North America Corp. and Qimonda Richmond
LLC. In November 2007 the parties settled and the case was
dismissed.
Accruals and the
potential effect of these lawsuits
Liabilities related to legal proceedings are recorded when it is
probable that a liability has been incurred and the associated
amount can be reasonably estimated. Where the estimated amount
of loss is within a range of amounts and no amount within the
range is a better estimate than any other amount or the range
cannot be estimated, the minimum amount is accrued. As of
December 31, 2007, the Company had accrued liabilities in
the amount of 77 related to the DOJ and European antitrust
investigations and the direct and indirect purchaser litigation
and settlements described above, as well as for legal expenses
relating to the securities class actions and the Canadian
antitrust investigation and litigation described above. As
additional information becomes available, the potential
liability related to these matters will be reassessed and the
estimates revised, if necessary. These accrued liabilities would
be subject to change in the future based on new developments in
each matter, or changes in circumstances, which could have a
material adverse effect on the Companys results of
operations and financial condition.
An adverse final resolution of the antitrust investigations or
related civil claims or the securities class action lawsuits
described above could result in substantial financial liability
to, and other adverse effects upon the Company, which would have
a material adverse effect on the Companys business,
results of operations, financial condition and cash flows. In
each of these matters, the Company is continuously evaluating
the merits of its respective claims and defending itself
vigorously or seeking to arrive at alternative resolutions in
the best interests of the Company, as its deems appropriate.
Irrespective of the validity or the successful assertion of the
above referenced claims, the Company could incur significant
costs with respect to defending against or settling such claims,
which could have a material adverse effect on the Companys
results of operations and financial condition and cash flows.
The Company is subject to various other lawsuits, legal actions,
claims and proceedings related to products, patents and other
matters incidental to its businesses. The Company has accrued a
liability for the estimated costs of adjudication of various
asserted and unasserted claims existing as of the balance sheet
date. Based upon information presently known to management, the
Company does not believe that the ultimate resolution of such
other pending matters will have a material adverse effect on the
Companys
28
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
financial position, although the final resolution of such
matters could have a material adverse effect on the
Companys results of operations or cash flows in the year
of settlement.
Contractual
Commitments
On October 8, 2007, Qimonda entered into a rental agreement
for new headquarter offices south of Munich, Germany. The
agreement involves the construction of a building by a third
party lessor, and includes a 15 year non-cancelable lease
term, which is expected to start in early 2010. Qimonda has an
option to extend the lease for two 5 year periods at
similar lease terms to the initial non-cancelable lease term.
The minimum rental payments aggregate 96 over the initial
lease term. The lease contract provides for rent escalation in
line with market-based increases in rent. The agreement will be
accounted for as an operating lease with monthly lease payments
expensed on a straight-line basis over the lease term.
The Companys operating lease expenses were 7 and
8 for the three months ended December 31, 2006 and
2007, respectively. Operating lease payments include amounts
paid to Infineon for lease payments. Premises currently occupied
by the Company that are leased by Infineon are expected to be
the subject of a sublease agreement between Infineon and the
Company.
Other
Contingencies
The Company has received government grants and subsidies related
to the construction and financing of certain of its production
facilities. These amounts are recognized upon the attainment of
specified criteria. Certain of these grants have been received
contingent upon the Company maintaining compliance with certain
project-related requirements for a specified period after
receipt. The Company is committed to maintaining these
requirements. Nevertheless, should such requirements not be met,
as of December 31, 2007, a maximum of 409 of these
subsidies could be refundable.
The Company has guarantees outstanding to external parties of
137 as of December 31, 2007, that mainly expire
through 2013. Guarantees are mainly issued by Infineon for the
payment of import duties, rentals of buildings, contingent
obligations related to government grants received and the
consolidated debt of subsidiaries. Such guarantees which relate
to Qimonda AG were transferred to the Company as part of the
Formation. The Company also agreed to indemnify Infineon against
any losses it may suffer under several guarantee and financing
arrangements that relate to its business but that cannot be
transferred to it for legal, technical or practical reasons.
The Company, through certain of its sales and other agreements
may, in the normal course of business, be obligated to indemnify
its counterparties under certain conditions for warranties,
patent infringement or other matters. The maximum amount of
potential future payments under these types of agreements is not
predictable with any degree of certainty, since the potential
obligation is contingent on conditions that may or may not occur
in future, and depends on specific facts and circumstances
related to each agreement. Historically, payments made by the
Company under these types of agreements have not had a material
adverse effect on the Companys business, results of
operations or financial condition.
|
|
18.
|
Operating Segment
and Geographic Information
|
The Company has one operating segment, Memory Products, which is
also its reportable segment, consistent with the manner in which
financial information is internally reported and used by the
Chief Operating Decision Maker for purposes of evaluating
business performance and allocating resources.
29
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
The following is a summary of net sales by geographic area for
the three months ended December 31, 2006 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, 2006
|
|
Three months ended December 31, 2007
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany
|
|
|
87
|
|
|
7%
|
|
|
36
|
|
|
7%
|
Rest of Europe
|
|
|
142
|
|
|
12%
|
|
|
50
|
|
|
10%
|
North America
|
|
|
474
|
|
|
40%
|
|
|
176
|
|
|
34%
|
Asia/Pacific
|
|
|
360
|
|
|
31%
|
|
|
184
|
|
|
36%
|
Japan
|
|
|
110
|
|
|
10%
|
|
|
67
|
|
|
13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,173
|
|
|
100%
|
|
|
513
|
|
|
100%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For practical purposes, the Rest of Europe region also includes
other countries and territories in the rest of the world outside
of the listed main geographic regions with aggregate sales
representing no more than 2% of total sales in any period. In
addition, prior period amounts have been reclassified to conform
to the current period presentation.
The Company defines EBIT as earnings (loss) before interest and
taxes. The Companys management uses EBIT, among other
measures, to establish budgets and operational goals, to manage
the combined and consolidated Companys business and to
evaluate and report performance as part of the Infineon Group.
Because many operating decisions, such as allocations of
resources to individual projects, are made on a basis for which
the effects of financing the overall business and of taxation
are of marginal relevance, management finds a metric that
excludes the effects of interest on financing and tax expense
useful. In addition, in measuring operating performance,
particularly for the purpose of making internal decisions, such
as those relating to personnel matters, it is useful for
management to consider a measure that excludes items over which
the individuals being evaluated have minimal control, such as
enterprise-level taxation and financing. The Company reports
EBIT information because it believes that it provides investors
with meaningful information about the operating performance of
the Company in a manner similar to that which management uses to
assess and direct the business. EBIT is not a substitute for net
income, however, because the exclusion of interest and tax
expense is not appropriate when reviewing the overall
profitability of the Company.
EBIT is determined as follows from the combined and consolidated
statements of operations, without adjustment to the
U.S. GAAP amounts presented:
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Net (loss) income
|
|
|
177
|
|
|
|
(598
|
)
|
Adjust:
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
74
|
|
|
|
9
|
|
Interest expense, net
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
EBIT
|
|
|
250
|
|
|
|
(590
|
)
|
|
|
|
|
|
|
|
|
|
Infineon reports the Companys EBIT results as its segment
net of the minority interest in Qimonda.
The following significant events occurred after
December 31, 2007:
On January 3, 2008 Qimonda announced that it signed an
agreement with Macronix International Co., Ltd., Taiwan, to
jointly develop non-volatile memory technologies. The
co-operation project is planned to focus on the development of
different kinds of non-volatile memory technologies over a
five-year timeline. Both partners will share development costs
and contribute engineering resources and know-how.
30
Qimonda AG and
Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial
Statements
(euro in millions, except where otherwise stated)
On January 11, 2008 the legal transfer from Infineon of the
Companys interest in AMTC became effective with the entry
in the commercial register. Similarly, on January 21, 2008
the legal transfer from Infineon of the Companys interest
in BAC became effective with the entry in the commercial
register.
On January 25, 2008 the court entered into an order
granting in part and denying in part the defendants motions to
dismiss the Securities Class Action complaint. The court denied
the motion to dismiss with respect to plaintiffs claims
under §10(b) and §20(a) of the Exchange Act and
dismissed the claim under §20A of the Exchange Act with
prejudice.
On January 29, 2008, the court in the multi-district
antitrust-related litigation (note 17) entered an
order granting in part and denying in part the motion of the
defendants. The order dismissed a large percentage of the claims
of the indirect purchasers and granted leave to amend as to one
claim. No trial date has been set and no schedule is currently
in effect for class certification.
On January 29, 2008, the Company held its annual general
meeting of shareholders. The shareholders resolved to replace
the previous authorization of July 14, 2006 relating to the
issuance of securities with a new authorization to the
Management Board, effective until January 28, 2013, to
issue various types of securities having an aggregate face value
of up to the equivalent of 2,063.
On January 30, 2008 the Company obtained approval from the
European Union to receive subsidies of 166 from German
authorities in connection with the upgrade and expansion of its
production facilities in Dresden, Germany. The Companys
use of these subsidies depends on it making qualifying capital
expenditures in Dresden. These capital expenditures, which would
be substantial, are not currently included in the Companys
capital expenditures budget, which has been reduced in response
to current market conditions.
31
SUPPLEMENTARY
INFORMATION (UNAUDITED)
Gross and Net
Cash Position
Qimonda defines gross cash position as cash and cash equivalents
and marketable securities, and net cash position as gross cash
position less short and long-term debt. Since after its
Formation, Qimonda holds a substantial portion of its available
monetary resources in the form of readily marketable securities,
which for U.S. GAAP purposes are not considered to be
cash, it reports its gross cash position to provide
investors with an understanding of its overall liquidity. The
gross and net cash positions are determined as follows from the
condensed consolidated balance sheets as of September 30,
2007 and December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
As of September 30,
|
|
|
|
|
2007
|
|
As of December 31, 2007
|
|
Cash and cash equivalents
|
|
|
746
|
|
|
|
509
|
|
Marketable securities
|
|
|
265
|
|
|
|
237
|
|
|
|
|
|
|
|
|
|
|
Gross Cash Position
|
|
|
1,011
|
|
|
|
746
|
|
Less: Short-term debt and current maturities
|
|
|
(77
|
)
|
|
|
(68
|
)
|
Long-term debt
|
|
|
(227
|
)
|
|
|
(304
|
)
|
|
|
|
|
|
|
|
|
|
Net Cash Position
|
|
|
707
|
|
|
|
374
|
|
|
|
|
|
|
|
|
|
|
Return on Capital
Employed (RoCE)
In addition to EBIT, the Qimonda management committed itself
from the 2007 financial year to focus on measuring the
profitability of the Company compared to the capital that has
been required. Therefore the financial indicator Return on
Capital Employed (RoCE) was implemented to measure
this performance.
Earnings before interest, Capital Employed and RoCE are non-GAAP
financial measures. Reconciliations to the closest GAAP measures
net (loss) income, shareholders equity, and net (loss)
income to shareholders equity ratio, respectively, are
presented below. Capital Employed is the end period
shareholders equity less the net cash position. RoCE is
calculated as Earnings before Interest (EBI) divided by Capital
Employed. Quarterly RoCE calculations are annualized for
purposes of this ratio only, which may exceed reported annual
earnings and is not indicative of expected earnings in any
future period.
RoCE is determined as follows from the condensed consolidated
financial statements:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
As of
|
|
|
September 30,
|
|
December 31,
|
|
|
2007
|
|
2007
|
|
Shareholders Equity
|
|
|
3,517
|
|
|
|
2,873
|
|
Less: Net Cash Position
|
|
|
(707
|
)
|
|
|
(374
|
)
|
|
|
|
|
|
|
|
|
|
Capital Employed
|
|
|
2,810
|
|
|
|
2,499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Net income (loss)
|
|
|
177
|
|
|
(598)
|
Adjust: Interest income, net
|
|
|
1
|
|
|
1
|
|
|
|
|
|
|
|
Earnings (loss) before Interest
|
|
|
176
|
|
|
(599)
|
|
|
|
|
|
|
|
Net income (loss)/Shareholders Equity
|
|
|
18%
|
|
|
(83%)
|
Return on Capital Employed
|
|
|
22%
|
|
|
(96%)
|
Free Cash
Flow
Qimonda defines free cash flow as cash from operating and
investing activities excluding purchases or sales of marketable
securities. Free cash flow is not defined under U.S. GAAP
and may not be comparable with measures of the same or similar
title that are reported by other companies. Under SEC rules,
free cash flow is considered a non-GAAP financial
measure. It should not be considered as a substitute for, or
confused with, any U.S. GAAP financial measure. Management
believes the most comparable U.S. GAAP measure is net cash
provided by operating activities. Since Qimonda operates in a
32
capital-intensive industry, it reports free cash flow to provide
investors with a measure that can be used to evaluate changes in
liquidity after taking capital expenditures into account. It is
not intended to represent residual cash flow available for
discretionary expenditures, since debt service requirements or
other non-discretionary expenditures are not deducted. The free
cash flow is determined as follows from the Companys
condensed consolidated statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Three months ended
|
|
|
December 31, 2006
|
|
December 31, 2007
|
|
Net cash provided by (used in) operating activities
|
|
|
438
|
|
|
|
(158
|
)
|
Net cash used in investing activities
|
|
|
(208
|
)
|
|
|
(35
|
)
|
Thereof: Purchases of marketable securities available for sale
|
|
|
11
|
|
|
|
35
|
|
Proceeds from marketable securities available for sale
|
|
|
|
|
|
|
(59
|
)
|
|
|
|
|
|
|
|
|
|
Free cash flow
|
|
|
241
|
|
|
|
(217
|
)
|
|
|
|
|
|
|
|
|
|
Employees
As of December 31, 2007, Qimonda had 13,630 employees
worldwide, including 2,563 engaged in research and development.
Market for
ordinary shares
Qimonda AG ordinary shares are traded as American Depository
Shares (ADSs) on the New York Stock Exchange under the symbol
QI.
Financial
Calendar
Qimonda plans to announce results for its second quarter ending
March 31, 2008, on April 21, 2008.
Publication
date
February 1, 2008
Contact
information
Qimonda Technologies AG
Investor Relations
Gustav-Heinemann-Ring 123
81739 Munich, Germany
Phone: +49 89
60088-1200
E-Mail:
mailto:investor.relations@qimonda.com
Visit
http://www.qimonda.com/
for an electronic version of this report and other information.
33
Risk
Factors
As a company, we face numerous risks incidental to our business.
We face risks that are inherent to companies in the
semiconductor industry, as well as operational, financial and
regulatory risks that are unique to us. Risks relating to the
semiconductor industry include the cyclical nature of the
market, which suffers from periodic downturns and industry
overcapacity. Our production related risks include the need to
match our production capacity with demand, and to avoid
interruptions in manufacturing and supplies. We may be exposed
to claims from others that we infringe their intellectual
property rights or that we are liable for damages under
warranties. We are the subject of governmental antitrust
investigations and civil claims related to those antitrust
investigations. Financial risks include our need to have access
to sufficient capital and governmental subsidies, as well as
declines in our share price which may result in impairment
charges. Our regulatory risks include potential claims for
environmental remediation. We face numerous risks due to the
international nature of our business, including volatility in
foreign countries and exchange rate fluctuations.
These and other material risks that we face are described in
detail in the Risk Factors section of our annual
report on
Form 20-F
for the year ended September 30, 2007, which we have filed
with the U.S. Securities and Exchange Commission. A copy of
our
Form 20-F
is available at the Investor Relations section of our website
http://www.qimonda.com,
as well as on the SECs website,
http://www.sec.gov.
We encourage you to read the detailed description of the risks
that we face in our
Form 20-F.
The occurrence of one or more of the events described in the
Risk Factors section of the
Form 20-F
could have a material adverse effect on our company and our
results of operations, which could result in a drop in our share
price.
Forward-looking
Statements
This quarterly report contains forward-looking statements.
Statements that are not historical facts, including statements
about our beliefs and expectations, are forward-looking
statements.
These forward-looking statements include statements relating to
future developments of the world semiconductor market,
especially the market for memory products, Qimondas future
growth, the benefits of research and development alliances and
activities, our planned levels of future investment in the
expansion and modernization of our production capacity, the
introduction of new technology at our facilities, the
transitioning of our production processes to smaller structures,
cost savings related to such transitioning and other
initiatives, our successful development of technology based on
industry standards, our ability to offer commercially viable
products based on our technology, our ability to achieve our
cost savings and growth targets, and any further corporate
reorganization measures in that regard. These statements are
based on current plans, estimates and projections, and you
should not place too much reliance on them.
These forward-looking statements speak only as of the date they
are made, and we undertake no obligation to update any of them
in light of new information or future events. These
forward-looking statements involve inherent risks and are
subject to a number of uncertainties, including trends in demand
and prices for semiconductors generally and for our products in
particular, the success of our development efforts, both alone
and with our partners, the success of our efforts to introduce
new production processes at our facilities and the actions of
our competitors, the availability of funds for planned expansion
efforts, the outcome of antitrust investigations and litigation
matters, as well as other factors. We caution you that these and
a number of other important factors could cause actual results
or outcomes to differ materially from those expressed in any
forward-looking statement. These factors include those
identified under the heading Risk Factors in the
Form 20-F.
34
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
QIMONDA AG
|
|
Date: February 1, 2008 |
By: |
/s/ Kin Wah Loh |
|
|
|
Kin Wah Loh |
|
|
|
Chief Executive Officer and Chairman of the Management Board |
|
|
|
|
|
|
By: |
/s/ Dr. Michael Majerus |
|
|
|
Dr. Michael Majerus |
|
|
|
Chief Financial Officer and Member of the Management Board |
|
|